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Yet a little while, and the world seeth me no 
more; but ye see me: because I live, ye shall 
live also. 
(John 14:19) 
 
 
 
 
 
 
 
 
 
Abstract 
Freshwater planarian Schmidtea mediterranea is an emerging model for 
studying in vivo gene functions and regulation in native cell niches. The 
obligate asexual strain of this species reproduces by fission, in which 
succession of soma occurs without passing through the germline. To 
achieve this somatic immortality the somatic stem cells need to overcome 
the end replication problem. Therefore it can be hypothesised that somatic 
telomere maintenance in asexual S. mediterranea must possess a germ-
like property, with which age-related erosions can be adequately repaired. 
In this PhD project, the telomere repeat unit in S. mediterranea was 
confirmed to be the vertebrate-like TTAGGG. Attrition of whole body 
telomere length was found in ageing sexual worms and also in asexual 
worms which had not gone through recent fission events. Opposite 
telomere length dynamics were observed in regenerated samples of the 
two strains, with erosion in the sexuals and reset in the asexuals. The 
telomere maintenance was found to increase during regeneration in both 
strains, with a higher level of increase in asexual worms. A homolog of the 
telomerase reverse transcriptase subunit, Smed_Tert, was identified and 
characterised in this organism. High level of Smed_Tert expression was 
seen in germ cells in mature sexual worms and adult stem cells in asexual 
worms. Knockdown of Smed_Tert expression by RNA interference caused 
progressive telomere erosion, however effects on cell proliferation and 
viability have not been observed in knockdown samples. Four alternate 
splice isoforms of Smed_Tert were identified. The enhanced telomerase 
activity during regeneration correlates with a proportional increase in the 
full-length isoform and a decrease in isoforms with a truncated TRBD 
domain, suggesting a dominant negative regulation of telomerase by 
alternative splicing. Significant increase in the expression of the full-length 
isoform was seen in regenerating asexual samples but not in sexual 
strains, which correlates with their telomere length dynamics. It is hoped 
that the comparative studies between the sexual and asexual strains can 
improve our understanding of how soma can evolve to become an effective 
inheritable unit. 
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CHAPTER 1: INTRODUCTION 
 
1.1    Telomeres, Cellular Senescence, and Life Span 
1.1.1 The General Structure of Telomeres 
The telomere is a nucleoprotein complex at the end of eukaryotic 
chromosomes. It consists of a tandem G-rich DNA repeat which varies in 
repeating sequence and length between species. The very end of telomeres 
LV FKDUDFWHULVHG E\ D ¶ VLQJOH VWUDQGed overhang required to form the 
unique secondary structure of this chromosome region. Electron 
microscopy of cross-linked chomosomes from human cells has observed 
thH LQYDVLRQRI WKH¶ RYHUKDQJ LQWRDQ LQWHUQDO WHORPHULFVLWH IRUPLQJD
75-200 bp displacement loop (D-loop) at the site of invasion, and a closed 
circular structure between the chromosome end and the invasion site 
termed the t-loop (Griffith et al., 1999). The t-loop has been found in a 
wide variety of eukaryotic organisms such as human, mouse (Griffith et al., 
1999), the hypotrichous ciliate Oxytricha fallax (Murti and Prescott, 1999), 
the flagellate protozoan Trypanosoma brucei (Muñoz-Jordán et al., 2001), 
and the plant Pisum sativum (Cesare et al., 2003); and is therefore 
thought to be the most conserved feature of eukaryotic chromosome ends 
(reviewed in (de Lange, 2004)). In humans, telomeric DNA is bound by 
double stranded repeat binding proteins TRF1 (telomeric repeat binding 
factor 1) (Zhong et al., 1992, Chong et al., 1995) and TRF2 (Bilaud et al., 
1997), and a single stranded telomere binding protein POT1 (protection of 
telomeres 1) (Baumann and Cech, 2001) (reviewed in (De Boeck et al., 
2009)). Both TRF1 and TRF2 function as homodimers; they share a similar 
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protein structure, with a C-terminal Myb domain which confers their 
specificity to the telomeric DNA. The major difference between the two 
proteins resides at their N-terminal end, which is acidic in TRF1 and basic 
in TRF2 (Broccoli et al., 1997). TRF1 has the ability of induce DNA bending 
and looping, which assists the formation of the t-loop (Griffith et al., 1999, 
Bianchi et al., 1997)ZKLOH75) IDFLOLWDWHV WKH¶ RYHUKDQJ LQYDVLRQDQG
stabilises the D-loop (Griffith et al., 1999, Stansel et al., 2001). Both 
proteins negatively regulate telomerase function by sequestration of the ¶
overhang in the t-loop (Smogorzewska et al., 2000). Overexpression of 
wild-type TRF1 causes gradual telomere shortening, while expression of a 
dominant negative allele of TRF1 increases telomere length (van Steensel 
and de Lange, 1997). In contrast, overexpression of TRF2 was found to 
transiently decrease telomere length (Smogorzewska et al., 2000), and 
inhibition or deletion of TRF2 results in ORVVRI¶ RYHUKDQJDQGan ATM-
dependent activation of DNA damage signals, which leads to genome 
instability, chromosome end-to-end fusion, cellular senescence and cell 
death (van Steensel et al., 1998, Denchi and De Lange, 2007). POT1 was 
demonstrated to control the access RIWHORPHUDVHDQG¶HQGUHVHFWLRQLQJ
HQ]\PHV ZKLFK FRPELQDWRULDOO\ UHJXODWH WKH OHQJWK RI ¶ RYHUKDQJV
Furthermore, POT1 inhibits an ATR-mediated DNA damage response and 
prevents telomere dysfunctions (Denchi and De Lange, 2007) (reviewed in 
more detail in Chapter 6). 
 
These telomeric sequence binding proteins are additionally bound by RAP1, 
TIN2, and TPP1 to form a functional telomere complex called shelterin (see 
Figure 1.1 and 1.2). RAP1 (repressor activator protein 1) is recruited to the 
telomere by binding to TRF2, its overexpression causes telomere 
elongation in a telomerase-dependent manner (Li and De Lange, 2003), 
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however its inhibition by shRNA or dominant negative allele expression 
also results in telomere extension (O'Connor et al., 2004). Additionally, 
RAP1 interacts with proteins in DNA damage response pathways, including 
RAD50, MRE11, KU70/86 and PARP1, indicating a possible role of these 
proteins in telomere length dynamics (O'Connor et al., 2004). TIN2 (TRF1 
interacting nuclear protein 2) simultaneously binds to TRF1 (Kim et al., 
1999), TRF2, and TPP1 (Houghtaling et al., 2004) in the complex. It was 
shown to protect TRF1 from inhibition by tankyrase 1, and regulates 
telomere length by controlling the number of TRF1 molecules accumulated 
at the telomere (Ye and de Lange, 2004). TPP1 (TIN2 and POT1 interacting 
protein 1) bridges POT1 with the TIN2/TRF1/TRF2 complex, it was initially 
shown to inhibit telomerase access by pairing with POT1 (Liu et al., 2004a, 
Ye et al., 2004), recently this heterodimeric pair was found to also recruit 
telomerase by associating with the holoenzyme by the 
oligonucleotide/oligosaccharide binding (OB) fold in TPP1 (Xin et al., 
2007a). The pair was also demonstrated to enhance telomerase 
processivity E\ VORZLQJ GRZQ WKH GLVVRFLDWLRQ RI WHORPHUDVH IURP WKH ¶
overhang and increasing its translocation along the substrate (Wang et al., 
2007a, Latrick and Cech, 2010). 
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Figure 1.1 ± Schematic model of human shelterin in S-phase and 
G2 phase. Only the shelterin complex at the very end of the telomere is 
shown, binding of the same complex along the internal double stranded 
telomere is left out from the illustration. (Adapted from (Deng and Chang, 
2007)) 
 
Figure 1.2 ± Evolutionarily conserved telomere binding proteins 
(shelterin and CST complex). The similarities and differences in their 
functions between human, fission yeast, and budding yeast are illustrated. 
Evolutionarily conserved proteins are shown in the same colours. (Adapted 
from Subramanian and Nakamura, 2010) 
 
In summary, the shelterin complex acts as a protective cap which controls 
telomere maintenance and prevents chromosome ends from being 
recognised as double strand breaks which can trigger the ATM or ATR-
mediated DNA damage response pathways. Additionally, it shields 
chromosome ends from enzymatic degradation, non-homologous end 
joining (NHEJ), and homologous recombination which lead to rapid 
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telomere length alteration, genome instability, cell cycle arrest, and 
apoptosis.  
 
Comparative studies between organisms have revealed diverged structures 
of shelterin complexes and rapidly evolving functions of telomere related 
proteins (reviewed in (Subramanian and Nakamura, 2010)). Fission yeast 
Schizosaccharomyces pombe has only one double stranded telomere 
binding protein, Taz1, which is evolutionarily related to the human 
TRF1/TRF2 (Cooper et al., 1997). In contrast to the uncapped telomere 
phenotypes in human cells without TRF2, deletion of Taz1 in S. pombe 
induces NHEJ without significant activation of checkpoint proteins, and cells 
remain proliferative and viable with an increase in telomere length (Cooper 
et al., 1997, Miller and Cooper, 2003).  Rif1 (homolog of Rap1 interacting 
factor 1 in S. cerevisiae), a general DNA damage response protein which 
does not bind to normal undamaged telomeres in humans, was shown to 
associate directly with Taz1 in fission yeast telomeres and possess length 
regulation function (Kanoh and Ishikawa, 2001). Deletion of Pot1 in fission 
yeast produces severe chromosome fusions and cell death (Baumann and 
Cech, 2001), while inhibition of the gene in human cells results in a mild 
(2-fold) increase in telomere fusions, in contrast to 10-100 fold after TRF2 
inhibition (Hockemeyer et al., 2005), indicating a greater role of the single 
stranded telomere binding protein in telomere capping in S. pombe; 
alternatively, other proteins at this region may buffer the effect of POT1 
knockdown in humans. 
 
TRF1/TRF2-related proteins are absent in budding yeast Saccharomyces 
cerevisiae. Rap1 binds directly to the double stranded telomeric DNA 
(Conrad et al., 1990), recruiting Rap1-interacting factors Rif1 and Rif2 for 
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telomere length regulation (Hardy et al., 1992, Wotton and Shore, 1997) 
and prevention of Tel1 (ATM homolog)-mediated DNA damage responses 
(Hirano et al., 2009). Similar to Taz1 in S. pombe, conditional repression 
of Rap1 in budding yeast induces chromosome fusions by the NHEJ 
pathway (Pardo and Marcand, 2005). A homolog of Pot1 is absent in S. 
cerevisiae at the sequence level, instead Cdc13, which shares structural 
homology with Pot1, binds to the single stranded telomere (Garvik et al., 
1995), together with another two OB fold-containing proteins Stn1 and 
Ten1 which are also specific to single stranded telomeric sequence, forming 
a CST (Cdc13-Stn1-Ten1) complex ZKLFKFDSVWKH¶RYHUKDQJ (Grandin et 
al., 1997, Grandin et al., 2001). The CST complex is the telomere specific 
analogue of the heterotrimeric replication protein A (RPA) complex (Gao et 
al., 2007, Gelinas et al., 2009, Sun et al., 2009), it shields telomeres from 
Rad9-mediated checkpoint activation, inhibits NHEJ, controls C-strand 
resections, and regulates WHORPHUDVHDFFHVVWRWKH¶ overhangs (Grandin 
et al., 2001). Stn1 and Ten1 are also present in fission yeast, their deletion 
phenotypes are identical to Pot1 deletion which includes elongation of cells, 
cell death, and circularisation of chromosomes. However in contrast with 
the interaction between Cdc13-Stn1-Ten1 in S. cerevisiae, yeast two-
hybrid experiments detect interaction between Stn1-Ten1 and Pot1-Pot1 
but not between Stn1-Pot1 and Ten1-Pot1 in S. pombe, suggesting two 
independent single strand telomere binding complexes which are both 
required to prevent the DNA damage signal (Martín et al., 2007). The plant 
and mammalian counterparts of this complex have been identified in 
Arabidopsis thaliana, humans, and mice; the complex consists of CTC1, 
STN1, and TEN1, their functions are similar to the yeast homologs in 
telomere capping (Song et al., 2008, Surovtseva et al., 2009, Miyake et 
al., 2009). Mammalian CTC1 differs from the budding yeast Cdc13 in that 
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it does not bind specifically to telomere sequence (Miyake et al., 2009), 
and may function more generally as a cofactor of DNA polymerase-Į
primase to regulate DNA replication (Casteel et al., 2009). Nonetheless, 
inhibition of CTC1 in human cells causes DNA damage signals, defective 
chromosome segregations, sporadic loss of telomeres, and accumulation of 
¶RYHUKDQJs, indicating its essential role in telomere integrity (Surovtseva 
et al., 2009). The presence of the CST complex across eukaryotic species 
suggests that it may be the most conserved mechanism for telomere 
capping (reviewed in (Subramanian and Nakamura, 2010)). 
 
1.1.2 Telomere shortening and cellular senescence 
As a result of the replication of linear-structured eukaryotic chromosomes, 
the telomere erodes every time a cell divides (Olovnikov, 1971, Watson, 
1972, Olovnikov, 1973). At the final stage of lagging strand synthesis, the 
RNA primer at the most ¶HQGRIWKHODJJLQJVWUDQGLVGHJUDGHGDQGWKH
resulting lesion (generally 5 to 15 nucleotides in length)  cannot be 
UHSDLUHGE\FDQRQLFDO'1$SRO\PHUDVHDQGOLJDVH7KH¶HQGRIWKHQHZO\
V\QWKHVLVHG VWUDQGV WRJHWKHU ZLWK WKH ¶ HQG RI WKH RULJLQDO WHPSODWH
VWUDQGVDUH IXUWKHUGHJUDGHGE\ D¶-¶exonuclease activity (Makarov et 
al., 1997) UHVXOWLQJ LQ ¶ RYHUKDQJV WKDW DUH PDLQWDLQHG DW D FRQVWDQW
length and a decrease in the total telomere length (see Figure 1.3). 
Progressive loss of average telomere length with age has been observed in 
vivo and in vitro in mammals (Kveiborg et al., 1999, Vaziri et al., 1994, 
Fiset and Chabot, 2001). It was discovered that in some human epithelial 
cell types, telomere length decreases by 50-100 bp per population 
doubling, this accounts for 2-4 kb over the life time of a person (reviewed 
in (Deng and Chang, 2007)). 
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In addition to the gradual telomere loss due to the end replication problem, 
abrupt loss of telomeres can also occur. This sudden attrition can arise by 
oxidative damage-related single-strand breaks causing replication fork 
stalling and/or recombination (von Zglinicki et al., 1995, Sitte et al., 1998, 
Passos et al., 2007) unequal sister chromatid exchange (Baird et al., 2003, 
Baird, 2009), and intra-chromosomal telomeric recombination which 
results in formation of an extrachromosomal telomere loop and distal 
chromosome end deletion (Rubelj and Vondracek, 1999, Wang et al., 
2004). However these events occurred in ex vivo cell cultures, some with 
artificially induced stresses. In vivo observations indirectly suggest that 
intense and chronic psychological stress is linked to high oxidative stress, 
low telomerase activity, short telomere length, and early onset of ageing-
related diseases (Epel et al., 2004, Epel et al., 2006, Simon et al., 2006). 
The abundance of abrupt telomere length changes in vivo, where cells are 
in their native environments, the significance of these events in the stem 
cell pool, and their contributions to whole body ageing, require further 
experimental confirmation. 
 
Figure 1.3 ± The degradation model 
of telomere shortening. Following 
FRPSOHPHQWDU\ VWUDQG V\QWKHVLV WKH ¶
end of each strand is degraded by an 
exonuclease activity, resulting in a fixed 
OHQJWK RI ¶ RYHUKDQJ $GDSWHG IURP
(Makarov et al., 1997)) 
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When telomere length reaches a critical point, the structure of the 
protective cap complex cannot be maintained. This dysfunctional telomere 
is recognised as a double strand break, and is detected by sensor proteins 
such as MRE11, NBS1, and RAD50. These proteins activate a signal 
transduction pathway which involves the protein kinases ATM/ATR, 
followed by CHK1, CHK2, and p53, which triggers a tumour suppressing 
mechanism involving apoptosis or long term cell cycle arrest via the p21 
pathway (ie. cellular senescence) (reviewed in (Deng and Chang, 2007)). 
Additionally, the p16INK4a/pRb pathway has a similar effect on the induction 
of cellular senescence in humans (Shay et al., 1991), but not in mice (Yi et 
al., 2000). 
 
It was observed in human fibroblasts that telomere-mediated cellular 
senescence involves two phases, mortality stages 1 and 2 (M1 and M2) 
(reviewed in (Yi et al., 2000)). M1 corresponds to the stage in which 
telomere(s) reaches a certain length that is detected by the DNA damage 
checkpoint as a double strand break which requires repairing, this results 
in a cell cycle arrest mediated by the p53 and/or p16INK4a/pRb pathway. 
Mutations in these pathways, or expression of viral oncogenes can result in 
cells escaping from the cycle arrest and resuming division despite their 
short telomere. This will lead to M2 (sometimes termed the crisis stage), in 
which terminally short telomere(s) induces NHEJ, which leads to breakage-
fusion bridge, gross chromosomal rearrangements, and consequently 
apoptosis or necrosis. 
 
Cellular senescence may act as a suppressive mechanism to avoid rapid 
proliferation of tumour cells, however it was seen in human fibroblasts that 
senescent cells secrete pro-inflammatory factors which promote malignant 
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transformation and propagation of neighbouring epithelial cells (Krtolica et 
al., 2001). This recalls the evolutionary theory of antagonistic pleiotropy 
(Williams, 1957) in a way that the senescence mechanism favours 
individual fitness in early life by suppressing cancer development, while 
having an unselected chronic effect on promoting tumorigenesis as 
senescent cells accumulate in aged organisms (Krtolica et al., 2001). 
 
 
 
1.1.3 Telomere shortening, whole body ageing, and life span 
Cells without adequate telomere maintaining mechanisms have a finite 
capacity for replication. This cell division limit, originally documented in 
human normal fibroblast culture (Hayflick and Moorhead, 1961), is termed 
the Hayflick limit. Somatic stem cells in mortal organisms have 
characteristics of weak/incomplete telomere maintenance, and it can be 
hypothesised that the whole body ageing of an organism results from the 
gradual increase in the proportion of its stem cells, responsible for the 
homeostatic maintenance of its reproduction, defence, and repair 
functions, reaching their Hayflick limit and becoming senescent (reviewed 
in (Weinstein and Ciszek, 2002)). Ectopic activation of a telomere 
maintenance enzyme, telomerase, is able to delay cellular senescence in 
human cell lines (Bodnar et al., 1998). The correlation between telomere 
erosion with advancing age, both in whole body and in individual cell types, 
in addition to the anti-senescent effect of enhancing telomere 
maintenance, suggests an essential role for telomere length in determining 
the Hayflick limit of somatic stem cells, and the possible consequential 
effect on the life span of the organism. 
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In addition to the Hayflick limit theory, a lab strain of nematode 
Caenorhabditis elegans with long telomeric DNA generated by 
transgenically overexpressed HRP-1 protein has an increased life span 
(Joeng et al., 2004). HRP-1 is a homolog of human RNP A1, which was 
shown to bind specifically to single strand telomeres and regulate telomere 
length, possibly by recruiting and stimulating telomerase and DNA 
SRO\PHUDVH Į (LaBranche et al., 1998, Fiset and Chabot, 2001). The 
extended life-span in HRP-1 overexpressed samples is dependent on the 
activity of a Fork head transcription factor DAF-16, which has previously 
been found to affect the life span of the organism via insulin receptor-like 
signalling from the reproductive system (Ogg et al., 1997, Hsin and 
Kenyon, 1999), however it was found that the effect of long telomeres is 
independent of the cycling of the germ stem cells (Joeng et al., 2004). This 
suggests that telomere length can also affect the longevity of an organism 
independently of the replicative capacity of the stem cells. 
 
However, variations in the telomere length between different species do 
not correlate with the difference in their life spans. Comparison between 
human and mouse has revealed that lab mice have on average a much 
longer telomere (Kipling and Cooke, 1990), while having a much shorter 
life span. It was also found that cultured mouse embryonic fibroblasts 
enter a transient replicative senescence stage after 10-15 population 
doublings, despite the presence of intact telomeres and telomerase activity 
(Blasco et al., 1997). These findings suggest a difference in the limits of 
telomere length as a Hayflick limit determinant between human and 
mouse, and possibly between other long-lived and short-lived organisms. 
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Despite the small but significant negative correlation of telomere length 
with age, currently published data have shown that the mean terminal 
restriction fragment (TRF) lengths in older human individuals (usually 
above 7 kb) are still significantly longer than those in senescent cells 
(around 4 kb) (reviewed in (Baird and Kipling, 2004)). Moreover, a study 
looking at the in vitro replicative life span of fibroblasts explanted from 
donors of different ages has shown no significant difference between young 
and old cells (Cristofalo et al., 1998). With conventional TRF technique it is 
difficult to pin-point the length of telomere which triggers senescence, 
since it lacks the resolution for individual chromosome ends. Futhermore, 
samples used in the TRF study were obtained from native tissues, of which 
the mean TRF lengths represent the majority of cells which are more likely 
to be descendants of healthy proliferative stem cells instead of senescent 
cells. As seen in the hematopoietic compartment, a pool of quiescent stem 
cells exists, possibly in order to replace the rapidly-diving stem cells when 
they senesce (Fleming et al., 2008). It can therefore be hypothesised that 
the whole body ageing is caused by the senescence of a relatively small 
but rapidly dividing fraction of stem cells, of which the telomere lengths 
are not visible and neglected in conventional TRF analysis. The factors 
secreted by these cells, such as extracellular matrix-degrading enzymes, 
cytokines, and growth factors, compromise tissue functions and promote 
malignant transformation of neighbouring cells, and ultimately trigger 
tissue dysfunctions and cancers (Krtolica et al., 2001). Alternatively, 
telomere-independent factors such as oxidative stress may trigger cellular 
senescence and whole body ageing prior to telomere attrition in some 
individuals. 
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1.1.4 Telomere maintenance mechanisms 
The telomeres of actively dividing cells are predominantly maintained by 
the activity of enzyme telomerase. Telomerase is a ribonucleoprotein 
FRPSOH[ ZKLFK UHFRJQLVHV DQG ELQGV WR WKH ¶ RYHUKDQJ RI WKH WHORPHUH
during the S-phase of the cell cycle (Greider and Blackburn, 1985, Zhu et 
al., 1996). It contains an integral RNA subunit (TERC) with a telomere-
binding region which is complementary to the ¶ WHORPHUH HQG DQG DQ
adjacent region which acts as a template for the telomeric repeat synthesis 
(Greider and Blackburn, 1989). The reverse transcriptase subunit (TERT) 
catalyses the addition of new bases to ¶RYHUKDQJs according to the RNA 
template, resulting in elongation of the G-strand telomeres (Lingner et al., 
1997, Counter et al., 1997, Harrington et al., 1997). The complementary 
strand is then lengtheQHG E\ '1$ SRO\PHUDVH Į-SULPDVH XVLQJ WKH ¶
overhang as the template (Diede and Gottschling, 1999, Nozawa et al., 
2000). TERC and TERT are the two components required to reconstitute 
telomerase activity in vitro (Weinrich et al., 1997), while telomerase in 
vivo is bound with various factors important for the ribonucleoprotein 
stability and recruitment (reviewed in (Collins, 2006)), forming a large 
holoenzyme containing a dimer or multimer of TERC and TERT (Prescott 
and Blackburn, 1997, Beattie et al., 2001). In contrast to canonical reverse 
transcriptase enzymes, telomerase has a unique ability to synthesise 
multiple units of telomeric repeat with a short template, which is usually 
1.5 copies of the unit (Greider, 1991). This feature is achieved by 
translocating the catalytic site and RNA template along the strand, adding 
telomeric sequences repetitively (Peng et al., 2001). Telomerase can be 
found across the eukaryotes, from diplomonads (Malik et al., 2000) to 
human. Recruitment of telomerase to telomere ends by the shelterin 
complex and telomerase component was demonstrated in budding yeast 
 14 
 
by the interaction between Est1, which binds Tlc1 (yeast telomerase RNA 
subunit), and Cdc13 (Evans and Lundblad, 1999, Qi and Zakian, 2000, 
Bianchi et al., 2004). Two of the human Est1 homologs (EST1A and B) 
were also shown to be telomerase components. Both proteins bind to TERT 
independent of TERC, and EST1A shows high affinity to single stranded 
telomeric sequence (Snow et al., 2003). Overexpression of EST1A induces 
telomere uncapping (Reichenbach et al., 2003), suggesting its role in 
opening the t-loop structure which allows access of telomerase. 
 
TERC between organisms are highly diverged at the primary sequence 
level (reviewed in (Nugent and Lundblad, 1998)), despite the conserved 
functions of these RNAs.  Comparison of TERCs from distantly related 
ciliates has suggested a conserved secondary structure between species 
(Romero and Blackburn, 1991). This is supported by a phylogenetic study 
which discovered the consensus secondary structures in vertebrate TERCs, 
these include the pseudoknot domain, the CR4-CR5 domain, the H/ACA 
box, and the CR7 domain (Chen et al., 2000). Multi-species alignment of 
TERT protein has revealed a conserved general protein structure (see 
Figure 1.4, reviewed in (Kelleher et al., 2002)), with telomerase specific 
domains at both N and C-terminals, surrounding a reverse transcriptase 
(RT) catalytic domain which contains conserved sequence motifs (Motif 1, 
 $ %¶ & ' DQG ( ZLWK YLUDO UHYHUVH WUDQVFULSWDVHV DQG
retrotransposons (Nakamura et al., 1997). The N-terminal region (TEN) 
consists of two telomerase-specific sequences motifs (Motif GQ and DAT), 
it possesses affinity to single stranded DNA and is essential for the activity 
and processivity of telomerase (Xia et al., 2000, Armbruster et al., 2001, 
Jacobs et al., 2006, Romi et al., 2007, Lue, 2005), the sequence specificity 
of this protein-DNA interaction varies between organisms (Xia et al., 2000, 
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Sealey et al., 2009). Between the TEN and RT domain is the telomerase 
RNA binding domain (TRBD) which includes conserved Motif CP, QFP, and T 
(Friedman and Cech, 1999, Xia et al., 2000). This domain interacts with 
TERC and is essential for the functional multimerisation of telomerase 
components and ribonucleoprotein assembly (Moriarty et al., 2002, Bosoy 
et al., 2003). Differed from RTs of retrovirus and retrotransposons, a 
unique feature of TERT RT domain is the insertion of a conserved IFD motif 
EHWZHHQ0RWLI$DQG%¶ZKLFKLVUHTXLUHGIRUDNA primer recognition and 
processive addition of telomeric repeat (Lue et al., 2003). The C-terminus 
of the protein was also found to be essential for processivity (Peng et al., 
2001, Hossain et al., 2002, Huard et al., 2003). While having no significant 
sequence homology to retroviral RTs, this region of TERT may also form a 
³WKXPE´ GRPDLQ ZKLFK LV important for template/primer binding in its 
retroviral relatives (Peng et al., 2001, Hossain et al., 2002). 
 
 
 
Figure 1.4 ± A general TERT protein structure as represented by 
hTERT. Multi-species conserved sequence motives are illustrated as boxes 
with unique colours. TRBD: Telomerase RNA Binding Domain. 
 
Telomerase activity is absent in most normal somatic human tissues and 
mortal cell lines (LaBranche et al., 1998, Wright et al., 1996), where TERC 
is lowly expressed and TERT is either low or not detectable (Nakamura et 
al., 1997, Meyerson et al., 1997). While in telomerase-positive cancer cell 
lines, expression of both components is highly up-regulated (Nakamura et 
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al., 1997, Meyerson et al., 1997, Yi et al., 1999) which correlates with the 
requirement for counteracting the end replication problem in these rapidly 
dividing cells. Similarly, telomerase activity can be detected in some 
proliferative normal cell types; high level of activity is present in male 
germ cells and activated lymphocytes (Wright et al., 1996, Weng et al., 
1996), while low levels can be seen in peripheral blood lymphocytes and 
hematopoietic progenitor cells (Hiyama et al., 1995). Malfunctioning of this 
holoenzyme results in rapid telomere erosion and genome instability, which 
lead to depletion of proliferative cells due to replicative senescence or 
apoptosis (Lundblad and Szostak, 1989, Lee et al., 1998). While 
expression of exogenous TERT in somatic cell lines was found to restore 
the proliferative capacity and allow the cells to divide beyond their usual 
population doubling limit (Bodnar et al., 1998). It is estimated that 90%-
95% of human cancer cells are telomerase positive (reviewed in (Liu et al., 
2004b)), although this percentage is highly variable in different cancer 
types (such as 75%-95% in breast carcinoma, and 11%-45% in 
fibroadenoma) (reviewed in (Meyerson, 2000) ).  
 
Several alternative mechanisms for lengthening telomere (termed ALTs) 
were found in some telomerase-negative yeast strains, human cancer cells, 
and immortalised cell lines (reviewed in (Henson et al., 2002)). General 
characteristics of ALT cell populations include presence of ALT-associated 
promyelocytic leukaemia (PML) bodies, and a highly heterogeneous 
distribution of telomere lengths ranging from 3kb to 50kb, as measured by 
TRF analysis (Bryan et al., 1995). Fluorescent in-situ hybridisation (FISH) 
on metaphase chromosomes has shown that this heterogeneity is present 
within individual cells, in which some chromosome ends are barely 
detectable, while some have very strong signals (Perrem et al., 2001). 
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These data suggests that homologous recombination events have occurred 
between chromosome ends, with which critically short ends obtain a 
section of telomeric sequence from longer ends. This mechanism results in 
rapid changes in telomere lengths, in contrast with the ends maintained by 
telomerase which are relatively constant (reviewed in (Henson et al., 
2002)). Another possible ALT mechanism involves the single-VWUDQGHG ¶
overhang invading a homologous double-stranded telomeric repeat array, 
followed by the synthesis of new telomeric sequences at the site of 
invasion (proposed by (Henson et al., 2002)). This is similar to the 
formation of t-loop at the G2 phase of normal cells, except that the 
replication event in normal cells is inhibited, possibly by the presence of 
POT1 proteins (Baumann and Cech, 2001). In addition to the same 
chromosome end, the invasion can also occur in different telomeres or 
extrachromosomal telomeric repeat DNA (ECTR) (Regev et al., 1998, Ogino 
et al., 1998). It is hypothesised that the ECTR sequences present in ALT 
cells can elongate telomeres by end-joining, homologous recombination, or 
act as templates for telomere synthesis (Henson et al., 2002). The ALT-
associated PML body (APB) contains proteins that are mostly involved in 
DNA break repair via recombination, such as RAD52, RAD51, and the 
MRE11/RAD50/NBS1 complex. As shown by yeast homologs, Rad51 is 
required for the type 1 telomerase-null survival pathway, which involves 
DPSOLILFDWLRQRIVXEWHORPHULF<¶HOHPHQWs; while Rad50 is required for the 
type II pathway which elongates the telomeric TG(1-3) repeat; and Rad52 
is required for both types (Le et al., 1999). Recent data has shown that the 
APB is not required for ALT in some human cell lines, the telomere length 
distributions in these cells resembles those of normal ALT cells, while the 
contents of their telomeres contain a large proportion of non-telomeric 
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sequences (Fasching et al., 2005), similar to the telomeres of S. cerevisiae 
type 1 survivor cells. 
 
An unusual telomere maintaining mechanism was found in Drosophila 
melanogaster (Biessmann et al., 1990) and some other Dipteran 
drosophilids (Casacuberta and Pardue, 2003). This involves attachment of 
non-long-terminal repeat retrotransposons, HeT-A and TART, to 
chromosome ends. This transposition-based mechanism results in very 
heterogeneous and non-specific DNA sequences in the telomeres. Unlike 
the end-capping protein complex previously discussed, the capping 
complex in D. melanogaster appears to bind to any stable chromosome 
ends, in a sequence-independent manor (Fanti et al., 1998), suggesting a 
higher tolerance to telomere-deletion events. A similar mechanism was 
also suggested in telomerase and RAD52-defective PAL survivors in 
budding yeast (Maringele and Lydall, 2004). 
 
1.1.5 Regulation of telomerase 
In addition to recruitment by shelterin and CST complex, and factors 
affecting processivities reviewed in previous sections, telomerase is also 
regulated by various other mechanisms (reviewed in (Liu et al., 2004b, 
Flores et al., 2006)). The fact that the transcription of TERT, relative to 
TERC, varies and correlates to a larger extent with the telomerase activity 
between mortal and immortal cell lines suggests its prominent and rate-
limiting role in telomerase regulation in human (Meyerson et al., 1997).  In 
contrast, expression of TERC in mouse tissues correlates strongly with 
telomerase activity (Blasco et al., 1995), suggesting different roles of TERT 
and TERC in telomerase regulation in different organisms. Various binding 
sites of transcriptional regulators have been identified in the promoter 
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region of human TERT (hTERT). c-Myc, which is involved in cell 
proliferation and differentiation (Henriksson and Lüscher, 1996), was found 
to directly activate hTERT through an E-box site in the promoter 
(Greenberg et al., 1999, Wu et al., 1999); while its antagonist, Mad, was 
found to repress hTERT (Günes et al., 2000, Oh et al., 2000). The ratio of 
c-Myc and Mad in normal somatic cells and immortal cells correlates with 
their telomerase activities (Oh et al., 2000). Similarly, upstream 
stimulatory factors (USF) 1 and 2 utilise two E-boxes in hTERT promoter as 
heterodimers, their activator effect can be enhanced by cofactor p300 and 
reduced by inhibition of p38 MAP kinase in immortalised cell lines but not 
in mortal cells (Goueli and Janknecht, 2003). The signal transducer and 
activator of transcription 3 (STAT3) was also shown to bind directly and 
activates hTERT promoter, and hTERT expression is required for survival of 
STAT3-dependent tumour cells (Konnikova et al., 2005). Tissue-specific 
regulation of hTERT was demonstrated by an estrogen response element in 
the promoter, which directly associates with WKH HVWURJHQ UHFHSWRU Į
together with the activation of c-Myc, estrogen confers specific telomerase 
up-regulation in mammary and ovarian epithelial cells (Kyo et al., 1999, 
Misiti et al., 2000). A majority of hTERT repressors currently found belong 
to tumour suppressors and oncogenic pathways, such as RAK/BRIT1 (Lin 
and Elledge, 2003) and p53 (through interaction with transcription factor 
Sp1, which binds to the five GC-boxes in the promoter (Kanaya et al., 
2000)). In addition, the human T-cell leukaemia virus type 1 oncoprotein 
Tax was found to suppress hTERT expression by competing with c-Myc for 
DNA binding specifically in pre-leukaemic cells (Gabet et al., 2003). The 
transforming growth fact beta (TGF-ǃ) can also repress hTERT expression, 
mediated by Smad-interacting protein 1 (SIP1), while Menin directly 
represses hTERT (Lin and Elledge, 2003). The transcription factor E2F-1,2 
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and 3, but not E2F-4 and 5, was found to reduce hTERT promoter activity 
in tumour cells by inhibition of Sp1-mediated activation, in contrast, all E2F 
factors activate hTERT in normal somatic fibroblast lines through a non-
canonical E2F site (Crowe et al., 2001, Won et al., 2002). Additionally, 
hTERT promoter contains the transcription factor activator protein (AP-1) 
binding site, which mainly associates with c-Jun, JunD, and c-Fos to 
suppress hTERT expression (Takakura et al., 2005). Several binding motifs 
for myeloid-specific zinc finger protein 2 (MZF-2) were also identified in the 
promoter, and overexpression of MZF-2 in cancer cell lines leads to 
reduction of hTERT expression and telomerase activity (Fujimoto et al., 
2000). 
 
In addition to the promoter-binding factors, the hTERT promoter contains 
clusters of CpG dinucleotides which are subject to DNA methylation, which 
can cause transcriptional silencing (Horikawa et al., 1999). However the 
methylation states between different cells are not consistent with their 
telomerase activities (reviewed in (Liu et al., 2004b)). While 
hypermethylation of the hTERT promoter was found to inhibit hTERT 
expression in normal oral fibroblasts and senescent normal oral 
keratinocytes (Shin et al., 2003), some undifferentiated and 
untransformed mortal telomerase-negative cells were found to possess 
hypomethylated hTERT promoters (Dessain et al., 2000, Lopatina et al., 
2003), and some transformed or neoplastic cells have their endogenous 
hTERT reactivated despite their hypermethylated promoters (Guilleret et 
al., 2002). These results indicates that the binding of transcriptional 
regulators to the hTERT promoter is only partly affected by DNA 
methylation, and this epigenetic influence seems cell type specific. 
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Alternative splicing of TERT mRNA can affect telomerase activity as well 
(more detail in section 5.1.1). Although the splicing isoforms include both 
exon-exclusion and intron-insertion variants, studies have only been done 
on transcripts with excluded exons. While only the constitutively spliced full 
length transcript gives rise to catalytic activity (Yi et al., 2000, Ulaner et 
al., 2000), WKH LVRIRUP K7HUWĮ Zhich contains an in-frame truncation of 
Motif A in the RT domain, acts as a dominant negative inhibitor of 
endogenous telomerase activity when overexpressed in immortalised and 
cancer cell lines (Colgin et al., 2000, Yi et al., 2000). Splicing isoforms 
were also recently identified in a chicken MDV lymphoma-derived MSB-1 T-
cell line (Amor et al., 2010). Isoforms with in-frame exon exclusions were 
shown to be inactive, and account for the majority of chTERT transcript in 
normal T-cells, which possess low telomerase activity. Isoforms with 
premature STOP codons were hypothesised to be subjects of nonsense 
mediated decay (NMD), this was confirmed in the most abundant variant of 
this type by RNAi against the NMD pathway. During MDV induced 
lymphomagenesis, up-regulation of telomerase activity coincides with 
increased proportion of the constitutively spliced transcript and a shift of 
inactive transcripts from in-frame variants to NMD-targeted variants (Amor 
et al., 2010). 
 
Post-translational modifications were also shown to affect telomerase 
activity. Both hTERT and TP1 proteins are subjects of phosphorylation by 
3URWHLQ .LQDVH &Į 3.&Į DQG GHSKRVSKRU\ODWLRQ E\ 3URWHLQ 3KRVSKDWDVH
2A (PP2A) in breast cancer cells (Li et al., 1997, Li et al., 1998). Treatment 
of breast cancer cell extracts with PP2A causes an inhibition of the cellular 
telomerase activity, whiFKLVUHYHUVLEOHZLWK3.&ĮWUHDWPHQW. Similarly, Akt 
Protein Kinase was found to phosphorylate and enhance hTERT in a 
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melanoma cell line (Kang et al., 1999). In addition to tumour cell lines, 
regulation of hTERT by phosphorylation was also observed in normal 
human T lymphocytes. Despite the significant difference in telomerase 
activity between thymocytes and blood peripheral T cells, the transcription 
levels of hTERT in these cells are equivalent, and up-regulation of 
telomerase activity during CD4+ T cell activation does not involve net 
increase in hTERT protein. Instead, hTERT protein is phosphorylated and 
recruited into the nucleus upon T cell activation (Liu et al., 2001). 
 
1.2   Telomeres and stem cells in planarians 
1.2.1 Stem cells of potentially immortal worms 
Planarians are free-living flatworms that belong to the phylum 
Platyhelminthes. Classical experiments have discovered that these 
organisms have the ability to regenerate complete animals from almost 
any fragment of the body, given that the fragment contains enough adult 
somatic stem cells ((Randolph, 1897, Morgan, 1898) reviewed in 
(Newmark and Alvarado, 2002)). It was found in Dugesia lugubris that a 
fragment as small as 1/279 of the worm is capable of full regeneration. 
Additionally, fragments from the pharynx and the region anterior to the 
eyes were found to be post-mitotic and unable to regenerate (Morgan, 
1898). 
 
The adult somatic stem cells in planarians, termed the neoblasts 
(Randolph, 1892), are pluripotent proliferative cells which give rise to the 
regeneration capacity and long term viability of the species (Baguñà, 
1976a, Baguñà, 1976b, Baguñà et al., 1989). During regeneration, 
neoblasts divide and differentiate into missing tissue types, while the 
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existing tissues are modified according to the new body plan (Morgan, 
1901, Baguñà, 1976b). During the homeostatic cell turnover of intact 
worms, neoblasts produce progeny which can further differentiate to 
replace aged cells (Baguñà, 1976b, Pellettieri and Alvarado, 2007, 
Eisenhoffer et al., 2008). Neoblasts are described as small (5-10 ǋP LQ
diameter) cells with large nuclei and very little cytoplasm ((Hayashi et al., 
2006), reviewed in (Reddien and Alvarado, 2004)), they are scattered 
throughout the parenchyma, and are capable of migrating to the wound 
site and form a regeneration surface termed the blastema (Baguñà, 
1976b). X-irradiation has been applied as a method to remove proliferative 
cells in planarians, which results in the inability to form and maintain 
blastema, loss of regeneration capacity, as well as disruptions of 
homeostatic functions, which ultimately leads to the death of the organism 
(Bardeen and Baetjer, 1904). In addition, transplantation of single 
clonogenic neoblasts into irradiated planarians restores their regeneration 
capacity and long-term viability, providing evidence for the pluripotency of 
this  cell type (Wagner et al., 2011). 
 
Recent studies of irradiation sensitive cells in planarian, including 
expression pattern of cell markers (such as Smedwi-1/2 (Reddien et al., 
2005), Smedwi-3 (Palakodeti et al., 2008) and Smed-Cbx-1 (Eisenhoffer et 
al., 2008)) and fluorescence activated cell sorting (FACS) of whole body 
cells (Hayashi et al., 2006), have revealed various sub-populations of 
neoblast. Within the irradiation sensitive cells, the X1 population sorted by 
FACS are proliferative (>2N DNA content, ~20% in S phase and ~75% in 
G2/M) with a size of approximately 10µm in diameter, while X2 cells are 
mainly non-cycling (~75% in G0/G1) and are 6µm in diameter (Hayashi et 
al., 2006, Eisenhoffer et al., 2008). 
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their rate of disappearance after irradiation (Eisenhoffer et al., 2008). The 
Category 1 cells are eradicated within 24 hours after irradiation, while 
Category 2 takes two days and Category 3 takes three to four days. Cell 
lineage tracing using a pulse treatment of 5-bromo-2-deoxyuridine (BrdU), 
a traceable analogue of thymidine which can be incorporated into the 
newly replicated genome during S-phase, has demonstrated that the 
different categories of cells represent the progress of neoblast 
differentiation towards post-mitotic progenies ((Eisenhoffer et al., 2008), 
see Figure 1.5). When combined with FACS, the X1 population contains a 
high proportion of cells expressing Category 1 markers (30% - 80%, 
varied between each marker), while X2 contains a mixture of category cells 
(23% - 44% Category 1, 8.5% Category2, and 12% Category 3). It is 
uncertain whether cells expressing different Category 1 markers with 
various expression patterns differ in their tissue specificities. 
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Figure 1.5 ± Anterior distribution and lineage tracing of category 
cells. (A) Fluorescent in-situ hybridisation with category markers (Cat1: 
Smed-wi1; Cat2: NB.21.11e; Cat3: Smed-AGAT1) showing the spatial 
distribution of stem cells and descendants at the anterior end of S. 
mediterranea. (B) Localisation of category markers after a single pulse of 
BrdU treatment, showing the progressive anterior migration of BrdU 
positive cells and the co-localisation of BrdU and category markers in a 
time-specific manner. White dots refer to cells with overlapping marker 
signals. *: Photoreceptors. Scale bar: 100µm. (Adapted from Eisenhoffer 
et al., 2008) 
 
1.2.2 A simple planarian model for complex questions 
The model planarian species used in this PhD project, Schmidtea 
mediterranea, has the ability to derive clonal lines from single worms due 
to its regeneration and homeostatic capacity, given that appropriate 
nutrients are provided. The species is divided into asexual and sexual 
strains, which differ genomically by a translocation between Chromosome I 
and III in the asexual strain (Baguñà et al., 1999). The sexual strain is 
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hermaphroditic, its germ cells are specified at no later than stage 8 during 
embryogenesis (Handberg-Thorsager and Salo, 2007), and develop into 
gamete-producing testes and ovaries in mature adults. However the adult 
somatic stem cells seem also capable of differentiating into germ cells, 
since nanos-positive germ cells are reconstituted in regenerating worms 
recovered from amputated body fragments deprived of nanos-expressing 
cells (Wang et al., 2007b). The asexual strain lacks reproductive organs, 
and reproduces by fission, in which a segment most posterior of the tail is 
pulled off from the body, followed by regeneration of the two body parts 
into two individual worms. This reproductive cycle is constantly repeated 
throughout the evolution history of the asexual strain, suggesting that the 
soma has become an effective inheritable unit which can propagate without 
need to passage through the germline. Therefore powerful cellular 
maintenance mechanisms must exist in planarians, with which telomeres 
must not erode, oxidative stresses must be removed, and DNA damage 
must be sufficiently repaired in order to prevent stem cell depletion after 
finite population doublings.  
 
It is not certain whether stem cells in the sexual strain also possess this 
immortal property, some early research has suggested limited life span in 
closely related sexual planarian species, such as Phagocata velata (Child, 
1914) and Dugesia lugubris ((Haranghy and Balázs, 1964) and citations 
within). Recent work in a sexual marine flatworm Macrostomum lignano 
has provided an accurate demography which shows the limited lifespan of 
this species (Mouton et al., 2009). It has been suggested that in 
multicellular organisms which sequester germ lines, the function of the 
soma is to increase the possibility of successful inheritance of germline to 
the next generation, and is susceptible to senescence after reproduction is 
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complete (Weismann, 1891). A common theory for ageing in multicellular 
organisms is the pleiotropic effect of genes which are naturally selected to 
maximise the fitness of soma at the sexually reproductive stage of life, 
while being deleterious at later stages since fitness of the soma after 
reproduction may not be the subject of natural selection (Williams, 1957). 
Alternatively, ageing may be selected for in a population with limited 
resources, in order to prevent inter-generational competition and maximise 
the survival of offspring (Weismann, 1891). Since offspring contain diverse 
genetic combinations arisen from meiotic recombination and mating, and 
the population relies on these variations to defend against constantly-
evolving environmental challenges such as parasites and pathogens (Red 
Queen hypothesis, (Hamilton, 1980)), ageing may act as a mechanism to 
prevent older individuals from dominating the gene pool (Goldsmith, 
2008). The study of ageing in planarians has not been pursued with 
molecular tools. S. mediterranea possess naturally occurring strains with 
different reproduction strategies, which can be used for testing the link 
between sexual reproduction and somatic senescence. 
 
The haploid genome of S. mediterranea consists of approximately 865Mb 
of A-T rich DNA sequence, distributed in 4 chromosomes ((Baguñà et al., 
1999, Prats, 1991), reviewed in (Newmark and Alvarado, 2002)). 
Compared to other planarian species that have more complex karyotypes 
(such as 15 chromosomes in S. polychroa) and ploidies (such as Dugesia 
lugubris which has triploid somatic cells, hexaploid female germ cells, and 
diploid male germ cells (Benazzi, 1957)), S. mediterranea has a stable 
diploid genome which can be easier to observe and study. The genome of 
the sexual S. mediterranea has been sequenced with moderate coverage 
(11.6 fold) (Washington University Genome Center and (Blythe et al., 
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2010)), and is ideal for both bioinformatic and experimental studies. 
However the sequence assembly is challenged by the AT-rich (greater than 
65%) nature and the repetitiveness (more than 40%) of the genome 
(Blythe et al., 2010). 
 
1.2.3 About this project 
The planarian telomeric repeat was originally identified in Polycelis tenuis, 
which contains the same repeat unit as the vertebrates, TTAGGG (Joffe et 
al., 1996). Preliminary bioinformatic analysis has identified several 
sequencing reads that may belong to the telomere and sub-telomeric 
regions (see section 3.1.1). In this PhD project, the (TTAGGG)n repeat in 
S. mediterranea was confirmed to be telomeric using Bal-31 exonuclease 
digestion followed by TRF analysis. Given the cell cycle dependent nature 
of the canonical telomerase mechanism, it is likely that a high telomere 
maintenance activity can be observed in worms during regeneration, when 
peaks of cell proliferation have been previously documented. To test this 
theory, telomere length dynamics were compared between homeostatic 
and regenerating samples from both sexual and asexual strains using a 
restriction digest-based and a qPCR-based technique. In order to confirm 
the activity of canonical telomerase enzyme, the telomere repeat 
amplification protocol (TRAP) assay was applied using total protein extracts 
from regenerating asexual samples. The same technique was used to 
compare the telomerase activity between homeostatic and regenerating 
samples of the two strains (see Chapter 3). The gene encoding the 
telomerase catalytic subunit, Smed_Tert, was identified and characterised 
in S. mediterranea. The spatial pattern of the gene expression was 
visualised by in-situ hybridisation. The function of Smed_Tert was studied 
using RNA interference (see Chapter 4). Four isoforms of Smed_Tert were 
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discovered by cloning of reverse transcription (RT)-PCR products, with one 
being the full-length transcript and the other three containing specific exon 
exclusions. Ratios of these isoforms in the transcriptome were measured 
with qRT-PCR and compared between the strains in intact and regenerating 
samples (see Chapter 5). With an aim to study the telomere dysfunctional 
phenotype, a shelterin component homolog, Smed_Pot1, was also 
identified and preliminarily characterised (see Chapter 6). Taken all 
together, S. mediterranea is a suitable model for studying how 
multicellular organisms can evolve to possess an immortal soma. It also 
provides an in vivo environment for studying telomere dynamics and 
telomere-related protein function in a native stem cell niche, and in a 
regenerative context. 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Materials 
2.1.1 Planarian culture 
Both the asexual and the hermaphroditic sexual strains of Schmidtea 
mediterranea were cultured by Mr. Jamie Jowett at 20°C using tap water 
filtered through activated charcoal and buffered with 0.5mM sodium 
hydrogen carbonate (Sigma). The worms were fed organic veal liver once 
per week, and were starved for at least 7 days prior to analysis or 
amputation. For the duration of experiments the worms were treated with 
10mg/ml gentamicin (Fluka) to prevent bacterial infections. 
 
2.1.2 Oligonucleotides 
All oligonucleotides were synthesised and desalted by Sigma-Aldrich, with 
details as follows (PCR linker sequences are shown in lower case): 
Description Primer name 6HTXHQFH¶Æ ¶ 
Amplifies the region for 
Smed_Tert dsRNA 
synthesis and in-situ 
hybridisation 
TERT_F2 ggccgcggCTTCAATATGTTGATGATGTT
TTATTC 
 
TERT_R gccccggccAATGGAGAATCCATTTCATT
TGACC 
 
Universal secondary 
PCR primer for adding 
T7 binding sites 
8QLB7B¶ GAGAATTCTAATACGACTCACTATAGg
gccgcgg 
 
8QLB7B¶ AGGGATCCTAATACGACTCACTATAGg
 31 
 
ccccggc 
 
Generation of pure 
staggered (TTAGGG)n 
dsDNA 
(TTAGGG)3 TTAGGGTTAGGGTTAGGG 
 
(CTAACC)3 CTAACCCTAACCCTAACC 
 
Primer for first strand 
cDNA synthesis 
OligodT18 GCGAGCACAGAATTAATACGACTCACT
ATAGGTTTTTTTTTTTTTTTTTTVN 
 
Amplifies the ORF of 
the full length transcript 
TERT_F7 ggccgcggATGGTTTTATGAAATTAGAT
CTTGG 
 
TERT_R As above 
 
qPCR for the total 
transcription level of all 
Smed_Tert isoforms 
TERT_qPCR_F3 TTATCGAGATTTGCAGGATT 
 
TERT_qPCR_R3 
 
CACTACAGCAATTGTCATGG 
qPCR for transcription 
level of Alt Region I 
+ve isoforms 
TERT_qPCR_Alt
I_F1 
 
TCTCGGCGATATTTTTCTAA 
TERT_qPCR_Alt
I_R1 
 
TCTTCATTGACTTGCATACG 
qPCR for transcription 
level of Alt Region I -ve 
isoforms 
TERT_qPCR_Alt
I_F2 
 
CAAAAACAAGTGTAGTGAAATTAAA 
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TERT_qPCR_Alt
I_R2 
 
CACCAGTGAAAATTTTGTTGA 
qPCR for transcription 
level of Alt Region II 
+ve isoforms 
TERT_qPCR_Alt
II_F1 
 
CTGATTTGATTTCGAAGACTAAAG 
TERT_qPCR_Alt
II_R1 
 
GAGGTATTCCGCATATTTGA 
qPCR for transcription 
level of cystatin 
(internal control) 
Cys_qPCR_F 
 
AACTCCATGGCTAGAACCGAA 
Cys_qPCR_R 
 
CCGTCGGGTAATCCAAGTACA 
qPCR for telomere 
repeat copy number in 
gDNA 
Tel_qPCR_F 
 
GGTTTTTGAGGGTGAGGGTGAGGGTG
AGGGTGAGGGT 
Tel_qPCR_R 
 
TCCCGACTATCCCTATCCCTATCCCTA
TCCCTATCCCTA 
qPCR for single copy 
gene NB.21.11e in 
gDNA (internal control) 
and as marker for 
Category 2 gene 
expression 
 
NB.21.11e_F 
 
GTCTCCCGCCAAATCAAGTA 
NB.21.11e_R 
 
TTTCATGCAATCTGCTTTCG 
qPCR marker for 
Category 1 gene 
expression 
Smedwi-2_F 
 
CTGCAAAAGATTACCTATGCTCTAACT 
Smedwi-2_R ACGGGATTAGAGCCCTTATGCAC 
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qPCR marker for 
Category 3 gene 
expression 
Agat1_F 
 
GTTGGTTGAAAAGCGAGAGGTT 
Agat1_R 
 
CGAACATCGGAAGTCCAACAATG 
Amplifies the region for 
Smed_Pot1 dsRNA 
synthesis 
POT1_F 
 
ggccgcggAAATACAGCCACGTTGAATC
CT 
POT1_R1 
 
gccccggccTACGATTTTACTGCTTTAAC
AGATG 
¶5$&(2XWHUUHYHUVH
primer (kit) 
 
¶2XWB5 GCGAGCACAGAATTAATACGACT 
¶5$&(2XWHUIRUZDUG
primer (Smed_Tert) 
 
7(57B¶2XWB) TTATCGAGATTTGCAGGATT 
¶5$&(2XWHUIRUZDUG
primer (Smed_Pot1) 
 
327B¶2XWB) TACGATTTTACTGCTTTAACAGATG 
¶5$&(,QQHUUHYHUVH
primer (kit) 
 
¶,QQB5 CGCGGATCCGAATTAATACGACTCACT
ATAGG 
¶5$&(,QQHUIRUZDUG
primer (Smed_Tert) 
 
7(57B¶,QQB) CTGTCTAGAGCCCCATGAAT 
¶5$&(,QQHUIRUZDUG
primer (Smed_Pot1) 
 
327B¶,QQB) CCTGAAAATCTCCCTAGGAT 
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¶5$&(51$$GDSWRU 
 
 GCUGAUGGCGAUGAAUGAACACUGC
GUUUGCUGGCUUUGAUGAAA 
¶5$&(2XWHUIRUZDUG
primer (kit) 
 
¶2XWB) GCTGATGGCGATGAATGAACACTG 
¶5$&(2XWHUUHYHUVH 
primer (Smed_Tert) 
 
7(57B¶2XWB5 TTTTTACAAGACATCGAGCA 
¶5$&(2XWHUUHYHUVH
primer (Smed_Pot1) 
 
327B¶2XWB5 AAATACAGCCACGTTGAATC 
¶5$&(,QQHUIRUZDUG
primer (kit) 
 
¶,QQB) CGCGGATCCGAACACTGCGTTTGCTG
GCTTTGATG 
¶5$&(,QQHUUHYHUVH
primer (Smed_Tert) 
 
7(57B¶,QQB5 CGCCTGAATAAGAATTTGAC 
¶5$&(,QQHUUHYHUVH
primer (Smed_Pot1) 
 
327B¶,QQB5 AAATACAGCCACGTTGAATCCT 
M13 primers M13_F 
 
GTAAAACGACGGCCAGT 
M13_R 
 
GCGGATAACAATTTCACACAGG 
Mariner1, target for 
TAR cloning 
Mar1_F 
 
tacgcgtcgacTAGTTTCCTGATTCCATCG
GCG 
Mar1_R tacgcgtcgacggatccTGGATATTCTGCC
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 GCAGGG 
 
 
2.1.3 Genomic contigs and trace sequencing reads 
All genomic contigs used in bioinformatic analysis were obtained from the 
sexual S.mediterranea genome assembly (version 3.1, Washington 
University Genome Center, 
http://genome.wustl.edu/genomes/view/schmidtea_mediterranea/), while 
the trace reads were acquired from the NCBI trace archive 
(http://www.ncbi.nlm.nih.gov/Traces/home/). 
 
2.1.4 TERT protein sequence in multiple species 
Sequences for multi-species TERT alignment were obtained from the NCBI 
RefSeq database (http://www.ncbi.nlm.nih.gov/protein) with the following 
details: 
Species Protein name Accession 
Caenorhabditis elegans Trt-1 NP_492373.1 
Homo sapiens TERT O14746.1 
Fugu rubripes TERT AAX59693.1 
Tetrahymena thermophila TERT O77448.1 
Saccharomyces cerevisiae Est2p Q06163.1 
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2.1.5 POT1 protein sequence in multiple species 
The following sequences of POT1 were obtained from the NCBI RefSeq 
database: 
Species Protein name Accession 
Schizosaccharomyces 
pombe 
POT1 CAB16192 
Arabidopsis thaliana AtPot1 AAX78213 
Xenopus laevis POT1 NP_001084422 
Gallus gallus POT1 NP_996875 
Mus musculus POT1a NP_598692 
Homo sapiens POT1 isoform 1 NP_056265 
 
2.1.6 Buffers and solutions 
1x TE pH 8.0:  
10 mM Tris-HCl, 1 nM EDTA 
10x TBE pH 8.3:  
890mM Tris, 890mM boric acid, 20mM EDTA 
 
2.1.6.1 For Southern hybridisation 
Church-Gilbert Buffer:  
0.5M Sodium phosphate buffer pH7.2, 1mM EDTA, 7% SDS 
Denaturing solution:  
1M NaCl, 0.5M NaOH 
20x SSC pH7.0:  
3M NaCl, 0.3M sodium citrate 
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2.1.6.2 For in-situ hybridisations and immunohistochemistry 
10x DIG rNTPs:  
3.57mM DIG-UTP, 6.43mM UTP, 10mM ATP, 10mM GTP, 10mM CTP 
10x PBS pH 7.2-7.4:  
1.369M NaCl, 26.827mM KCl, 14.696mM KH2PO4, 80.997mM anhydrous 
NA2HPO4 
ƙ+ROWIUHWHU¶VVROXWLRQ  
0.374M NaCl, 0.416M KCl, 0.567mM CaCl2, 1.488mM NaHCO3 
Carnoy solution [made fresh]:  
60% ethanol, 30% chloroform, 10% acetic acid 
Prehybridisation buffer:  
50% formamide, 5x SSC, 0.1mg/ml yeast total RNA (Ambion), 0.1mg/ml 
heparin (Roche), 0.1% Tween20; 10mM DTT 
Hybridisation buffer [made fresh]:  
10% dextran sulphate in prehybridisation buffer 
Proteinase K digestion buffer:  
50mM Tris pH 8.0, 10mM EDTA, 0.5% SDS 
PostHyb1 solution [made fresh]:  
50% formamide, 5x SSC 
PostHyb2 solution [made fresh]:  
75% PostHyb1 solution, 25% PostHyb5 solution 
PostHyb3 solution [made fresh]:  
50% PostHyb1 solution, 50% PostHyb5 solution 
PostHyb4 solution [made fresh]:  
25% PostHyb1 solution, 75% PostHyb5 solution 
PostHyb5 solution [made fresh]:  
2x SSC, 0.1% TritonX-100 
PostHyb6 solution [made fresh]:  
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0.2x SSC, 0.1% TritonX-100 
Buffer I pH7.5 [made fresh]:  
0.1% TritonX-100, 99.914mM maleic acid, 0.167M NaCl, pH adjusted with 
NaOH 
Buffer II [made fresh]:  
1% Blocking Reagent (Boehringer Mannheim) in Buffer I 
Resuspension buffer:  
PO)RUPDPLGHPO[7(S+ǋO7ZHHQ 
TMN solution [made fresh]:  
0.1M Tris-HCl pH9.5, 0.1M NaCl, 0.05M MgCl2, 1% Tween20, 10% 
polyvinyl alcohol (98-99%, hydrolysed) 
 
 
 
 
2.1.7 Vectors used in TA cloning 
pCR2.1-TOPO (Invitrogen) 
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pCR4-TOPO (Invitrogen) 
 
 
 
2.2 Methods 
2.2.1 RNA interference - Smed_Tert 
A 601bp section located across the Motif C, D, and E of the Smed_Tert 
transcript (PCR product from primer TERT_F2 and TERT_R) was amplified 
from first strand cDNA synthesised from total RNA extracted from asexual 
S. mediterranea (see section 2.2.10) using a gene specific primer set with 
¶OLQNHUV IRUZDUGSULPHUOLQNHU¶-ggccgcgg-¶UHYHUVHSULPHUOLQNHU¶-
gccccggcc-¶ which act as binding sites for  a ubiquitous secondary PCR 
primer set, ZKLFKDWWDFKHVD751$SRO\PHUDVHELQGLQJVLWHDWWKH¶HQG
of both strands (see section 2.1.2 for primer sequences). The secondary 
PCR product was used as a template for in vitro transcription with T7 RNA 
polymerase (Roche), the conditions of PCR and transcription reactions are 
listed as follows. 
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Primary PCR with gene-specific primers: 
Total reaction volume: 50µl  Cycling conditions/procedures 
Reagent Final 
concentration 
Step Temperature Duration 
10x NH4 Taq 
Buffer (Bioline) 
 
1x 1 94ºC 1 min 
50mM MgCl2 
 
1.5mM 2 94ºC 30 sec 
2mM dNTP 
 
0.2mM 3 54ºC 30 sec 
Primer: TERT_F2 
(10µM) 
 
300nM 4 72ºC 1 min 
Primer: TERT_R 
(10µM) 
 
300nM Repeat Step 2-4 34 Times 
cDNA 
 
1ng/µl 5 72ºC 2 min 
Taq polymerase 
(Bioline) 
 
0.06U/µl PCR product was gel-extracted with a 
Qiagen gel-extraction kit.  
Deionised water 
 
Fill to 50µl 
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Secondary PCR with universal T7 primers: 
Total reaction volume: 50µl  Cycling conditions 
Reagent Final 
concentration 
Step Temperature Duration 
10x NH4 Taq 
Buffer (Bioline) 
 
1x 1 94ºC 1 min 
50mM MgCl2 
 
1.5mM 2 94ºC 30 sec 
2mM dNTP 
 
0.2mM 3 55ºC 30 sec 
Primer: 
8QLB7B¶ 
(10µM) 
 
300nM 4 72ºC 1 min 
Primer: 
Uni_T7_3¶ 
(10µM) 
 
300nM Repeat Step 2-4 34 Times 
Purified primary 
PCR product 
 
0.02ng/µl 5 72ºC 2 min 
Taq polymerase 
(Bioline) 
 
0.06U/µl PCR product was checked on gel and 
purified with a Qiagen PCR purification 
kit. 
Deionised water 
 
Fill to 50µl 
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In vitro transcription: 
Total reaction volume: 40µl  Procedure 
Reagent Final 
concentration 
Incubated at 37ºC for 8.5 hours. 
10x transcription 
buffer (Roche) 
 
1x Added 2 units of TURBO DNAse 
(Ambion). 
20mM rNTP 3mM Incubated at 37ºC for 30 
minutes. 
 
Secondary PCR 
product 
 
20ng/µl Added 2.5µg of glycogen, 
precipitated with 510µl of EtOH 
at    -20ºC overnight. 
 
RNAseOUT RNAse 
inhibitor 
(Invitrogen) 
 
1U/µl Centrifuged at 12,000 x g for 30 
minutes, supernatant removed. 
T7 RNA polymerase 
(Roche) 
 
2U/µl Pellet washed with 1ml of 70% 
EtOH, then resuspended in 25µl 
of RNAse-free water. 
 
RNAse-free water 
 
fill to 40µl  
 
1:80, 1:40, 1:20 and 1:10 dilutions of the final product were run on a 1% 
agarose gel in 1 x TBE, and quantified using band intensity readings with 
the Quantity One software (BioRad); Q-step 4 DNA ladder (1425 ng/lane, 
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YOUBIO) was used as a quantitative standard. The double-stranded RNA 
was then diluted to 2 µg/µl, and 96.6nl (3 x 32.2nl) was injected into the 
gut branch of each planarian from the ventral side anterior to the pharynx 
using the Nanoject II (Drummond Scientific) apparatus. 7KH ´ JODVV
capillaries (Drummond Scientific) were pulled using a Flaming/Brown 
Micropipette Puller (Patterson Scientific), with the following settings: heat 
295, time 150, pull 200, and velocity 120. The experiment consisted of 
injections on three consecutive days of the first week, followed by 
maintenance injections at a frequency of twice a week. The negative 
control samples were injected with the same amount of dsRed double-
stranded RNA, of which no homologous gene is present in S. mediterranea. 
For telomere length analysis and TRAP assay, all samples were amputated, 
followed by extractions at 72 hours post-cut. 
 
2.2.2 RNA interference ± Smed_Pot1 
Double strand RNA was synthesised in vitro, using the same procedure as 
section 2.2.1, from a 309bp RT-PCR product which locates at the OB1 fold 
encoding region of the transcript. The conditions for the primary PCR are 
listed as follows: 
Total reaction volume: 50µl  Cycling conditions 
Reagent Final 
concentration 
Step Temperature Duration 
10x NH4 Taq 
Buffer (Bioline) 
 
1x 1 94ºC 1 min 
50mM MgCl2 
 
1.5mM 2 94ºC 30 sec 
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2mM dNTP 
 
0.2mM 3 55ºC 30 sec 
Primer:    
POT1_F  (10µM) 
 
300nM 4 72ºC 1 min 
Primer: 
POT1_R1 (10µM) 
 
300nM Repeat Step 2-4 34 Times 
cDNA 
 
1ng/µl 5 72ºC 2 min 
Taq polymerase 
(Bioline) 
 
0.06U/µl  
Deionised water 
 
Fill to 50µl 
 
The RNA was diluted to 2 µg/µl and 96.6nl was injected into the gut of 
each planarian as described above. The injection was done on three 
consecutive days per week, for a total of two weeks. The worms were 
amputated a day after the final injection. Homeostatic phenotypic 
observation was done with worms injected with the same regime and left 
without amputation. Control samples were injected with the same amount 
of dsRed double-stranded RNA. 
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2.2.3 Genomic DNA extraction 
Worms were frozen at -20ºC overnight in 300µl of lysis buffer (110mM 
NaCl, 110mM Tris-HCl pH8.5, 55mM EDTA pH8.0, and 1.14% SDS), 
followed by thawing and homogenising with a sterilised pestle on the 
second day. The pestle was washed with 200µl of lysis buffer, which was 
added into the homogenised sample. The 500µl sample was then digested 
with 0.1 mg/ml Proteinase K and 0.1 mg/ml RNAseA at 37ºC for 30 
minutes, then 65ºC for 30 minutes. The genomic DNA was purified with 
two basic Phenol (pH 8.0) extractions, followed by removal of residual 
phenol with a chloroform extraction, all centrifugation steps were done at 
4ºC. The sample was added with 4µg of glycogen, and then precipitated 
with 1ml of EtOH at -20ºC overnight. The sample was centrifuged at 
12,000 x g for 45 minutes at 4ºC, after which the supernatant was 
removed, and the pellet was washed twice in 1ml of 70% EtOH. The final 
product was resuspended in 1 x TE pH8.0, and quantified on a 1% agarose 
gel in 1 x TBE, as described in section 2.2.1. The DNA was stored at 4ºC. 
 
 
 
2.2.4 Effect of regeneration on telomere length 
For each sample, an intact worm was cut into head, middle, and tail 
pieces. gDNA from the tail piece was extracted immediately after the cut 
while the remaining pieces were allowed to regenerate. The regenerants 
were further cut 5 days and 10 days after the first amputation. gDNA was 
extracted after 3 rounds of regeneration. 
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2.2.5 TRF-Southern analysis 
ǋJRIJHQRPLF'1$ZDVGLJHVWHG WR FRPSOHWLRQE\$OX,+DH,,, DQG
MboI using the following procedure:  
Total reaction volume: 150µl  Procedures 
Reagent Final 
concentration 
Incubated at 37ºC for 16 hours. 
10x NEB Buffer 2 
 
1x Added with 9µl of 3M sodium acetate pH 
5.2 and 4µg of glycogen. 
 
MboI 
 
20U total Precipitated with 500µl of EtOH at -20ºC 
overnight. 
 
AluI 
 
20U total Centrifuged at 12,000 x g for 30 
minutes, supernatant removed. 
 
HaeIII 
 
20U total Pellet washed with 70% EtOH. 
gDNA 
 
650ng total Resuspended in 22µl of 1 x TE pH 8.0. 
Deionised water 
 
Fill to 150µl  
FIGE pulsefield electrophoresis was performed with the separation 
optimised for a range between 2kb and 35kb (see section 2.2.7 for details 
about FIGE settings). The DNA was denatured in the denaturing solution, 
transferred to a quaternary amine derivatised nylon membrane (Zeta-
Probe GT, Bio-Rad) in the denaturing solution using a 9DFX*HQH ;/
Vacuum Blotting System (Amersham), and probed with 32p labelled 
telomeric tandem repeat sequence produced by random primer labelling of 
a PCR product from a primer set which yields staggered pure (TTAGGG)n 
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sequence (Forward primer: (TTAGGG)3; Reverse primer: (CTAACC)3, gel-
purified between 300bp ± 2kb), the PCR was performed with the following 
conditions: 
Total reaction volume: 50µl  Cycling conditions 
Reagent Final 
concentration 
Step Temperature Duration 
10x NH4 Taq 
Buffer (Bioline) 
 
1x 1 94ºC 1 min 
50mM MgCl2 
 
1.5mM 2 94ºC 30 sec 
2mM dNTP 
 
0.2mM 3 55ºC 30 sec 
Primer:    
(TTAGGG)3 
(10µM) 
 
300nM 4 72ºC 1 min 
Primer: 
(CTAACC)3 
(10µM) 
 
300nM Repeat Step 2-4 34 Times 
Taq polymerase 
(Bioline) 
 
0.06U/µl 5 72ºC 2 min 
Deionised water 
 
Fill to 50µl  
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The Labelling reaction was done using the Prime-It® RmT Random Primer 
Labelling Kit (Stratagene) with the following protocol: 
Reagents Quantity 
 
 (TTAGGG)n probe 
 
Ladder probe 
(TTAGGG)n PCR product 
 
50ng 0 
Ǌ-HindIII digested DNA 
 
0 2ng 
5kb size standard 
(BioRad) 
 
0 2ng 
Reaction mix 
 
1 vial 1 vial 
Deionised water 
 
Fill to 44µl Fill to 42µl 
Denatured at 100ºC for 5 minutes 
 
Į-32p dCTP 3000Ci/mmol 
10mCi/ml (Perkin-Elmer) 
 
3µl 5µl 
Magenta polymerase 
(Stratagene) 
 
3µl 3µl 
Incubated at 37ºC for 20 minutes 
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STOP solution 
 
2µl 2µl 
Labelled probes were purified with Bio-spin 30 column (BioRad). 1µl of the 
ladder probe was added to the (TTAGGG)n probe, the mixture was 
denatured at 100ºC for 5 minutes, and chilled on ice for 5 minutes 
immediately before use. 
 
The membrane was pre-hybridised in Church-Gilbert Buffer at 64ºC for one 
hour, followed by addition of the probe mix to the pre-hyb buffer and 
hybridised at 65ºC overnight. The membrane was washed four times in 
3xSSC/0.1%SDS at 64ºC. The signal was visualised with a Fujifilm Super 
RX film and digitalised with an Epson V350 Photo scanner. The image was 
analysed with the Quantity One software (Invitrogen) and the mean 
WHORPHUHOHQJWKZDVGHILQHGDVƶ2'LƶODi/Li) as previously described 
(Harley et al., 1990), where an ODi is the optical density reading of one of 
the evenly distributed blocks in the lane, and Li is the mean DNA size of 
the same block. 
 
2.2.6 Bal-31 digestion followed by 6-cutter TRF analysis 
800ng of gDNA was treated with 1.5 units of exonulease Bal-31 in a 
reaction volume of 50µl for various durations (30, 60, 120, and 240 
minutes), followed by inactivation of the enzyme at 65ºC for 15 minutes in 
the presence of 20mM EGTA, and ethanol precipitation subsequently. The 
samples were resuspended in 1 x NEB Buffer 3 and then digested with a 
cocktail of 6-cutter restriction enzymes (including EcoRI, MluI, NruI, ScaI 
and PvuII, 10 units of each enzyme per sample) in a reaction volume of 
150µl, for 16 hours. The digested samples were ethanol precipitated and 
resuspended in 22µl of 1 x TE pH8.0. Separation was done with FIGE, 
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followed by the TRF southern hybridisation as described in section 2.2.5. 
For the internal gene control, the digested samples were probed with a 32p-
labelled PCR product of nanos gene. 
 
2.2.7 Field Inversion Gel Electrophoresis (FIGE) 
DNA samples in the TRF analysis were separated with a FIGE Mapper 
Electrophoresis System (Bio-Rad), using a customised program optimised 
for separation between 2 ± 35 kb with the following settings: 
Agarose 1.0% 
Buffer 0.5 TBE 
Temperature Room temperature 
Forward voltage 180 
Reverse voltage 120 
Switch time 0.1 ± 0.3 seconds 
Ramp 21p 
Run time 15.8 hours 
 
2.2.8 Telomere length measurement by qPCR 
The primers and cycling parameters were derived from Cawthon (Cawthon, 
2002). Reactions were done using Brilliant qPCR Master Mix (Agilent) with 
a Corbett Rotor-Gene 6000 qPCR machine. gDNA samples were diluted to 
10ng/µl and 30ng was used in each qPCR reaction. For telomere copy 
number, the final primer concentrations were: Tel_qPCR_F (270nM); 
Tel_qPCR_R (900nM), and the cycling was done with an initial incubation 
at 95ºC for 10 minutes, proceeded by 35 cycles of 95ºC for 15 seconds 
and 54ºC for 2 minutes. For the single copy internal control gene 
NB.21.11e, 300nM of final concentration was used for both primers, the 
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cycling was 95ºC for 10 minutes, followed by 40 cycles of 95 ºC for 15 
seconds, 55ºC for 20 seconds, and 72ºC for 20 seconds. Each sample was 
analysed in triplicate. 
 
2.2.9 Telomere repeat amplification protocol (TRAP) assay 
The assay was performed with the TRAPeze® Telomerase Detection Kit 
(Millipore). For each sample, 3 worms (approximately 8mm long) were 
snap-frozen with liquid nitrogen in 110µl of the CHAP buffer, with an 
addition of 200 U/µl of RNasin® Plus RNase Inhibitor (Promega). When 
thawed, the sample was homogenised on ice with an RNAse-free pestle, 
and was incubated on ice for 30 minutes. The suspension was then 
centrifuged at 12,000 x g for 20 minutes at 4ºC, and the supernatant was 
collected and quantified with Bradford assay. 0.5µg of the total protein was 
incubated with the TS Primer in 1x TRAP buffer, in presence of 50µM dNTP, 
for 45 minutes at 30ºC. The product DNA was purified with 
phenol/chloroform/isoamyl alcohol (25/24/1, pH8.0) followed by 
precipitation on dry ice with ethanol in presence of 2.5M ammonium 
acetate, desalt with 70% ethanol, and resuspension in 20µl of deionised 
water. PCR amplification of the product DNA was performed with the 
following conditions: 
 
 
Total reaction volume: 50µl  Cycling conditions 
Reagent Final 
concentration 
Step Temperature Duration 
10x TRAP Buffer 
 
1x 1 94ºC 1 min 
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2.5mM dNTP 
 
50µM 2 94ºC 30 sec 
50x TS Primer 
 
1x 3 59ºC 30 sec 
50x Primer Mix 
 
1x 4 72ºC 90 sec 
Taq polymerase 
(Roche) 
 
0.04 U/µl Repeat Step 2-4 34 Times 
  5 72ºC 2 min 
 
 
For each experiment, a positive control reaction was done with the same 
procedures using a telomerase-positive HeLa cell extract attached with the 
kit, while a negative control was performed using CHAP buffer only. The 
PCR products were run in a 10% non-denaturing PAGE gel (in 0.5x TBE), 
stained with SYBR® Green I (Invitrogen), and visualised with a Fuji 
FLA2000 phosphorimager. 
2.2.10 Total RNA extraction and first strand cDNA synthesis  
For each sample, planarians (5 individuals, each with a body length of 
approximately 5mm, or fewer worms with larger sizes) were snap-frozen in 
300µl of TRIzol reagent (Invitrogen) in dry ice and stored at -80ºC 
overnight, followed by thawing and homogenising with a motor-assisted 
pestle. 60µl of chloroform was added to the suspension, and mixed by 
vigorous shaking for 15 seconds. The mixture was centrifuged at 4ºC at 
12,000 x g for 15 minutes, and the upper aqueous layer was transferred 
into a fresh microcentrifuge tube. Total RNA was precipitated with 150µl of 
isopropanol at room temperature for 10 minutes, and pelleted by 
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centrifugation at 4ºC at 12,000 x g for 10 minutes. The supernatant was 
removed, the pellet was washed with 70% ethanol, and resuspended in 
17µl of RNAse-free water. The sample was added with 2µl of 10x TURBO 
DNAse Buffer (Ambion) and digested with 2 units of TURBO DNAse at 37ºC 
for 15 minutes. The reaction mixture was filled to 100µl with water, and 
then mixed with 100µl of acid phenol/chloroform/isoamyl alcohol (25/24/1, 
pH4.5) by vortexing, followed by centrifugation at 4ºC at 12,000 x g for 10 
minutes. The aqueous layer was collected, and extracted with 100µl of 
chloroform to remove residual phenol. The sample was precipitated with 
10µl of 3M sodium acetate pH5.2 and 350µl of ethanol, at -20ºC overnight. 
Following subsequent centrifugations and washings, the pellet was 
resuspended in 16µl of distilled water. 
 
The RNA was quantified with the Quant-L7 51$ $VVD\ .LW ,QYLWURJHQ
DQG  ǋJ ZDV XVHG LQ WKH O in vitro transcription reaction with 
OligodT18 primer, which binds to the poly-adenylated tails of mature 
mRNAs, and Superscript III reverse transcriptase (Invitrogen) with the 
following procedures: 
Reagents 
 
Quantity 
50µM OligodT18 
 
1µl 
10mM dNTPs 
 
1µl 
Total RNA 
 
4.5µg 
RNAse-free water 
 
Fill to 13µl 
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Incubated at 65ºC for 5 minutes, chilled on ice. 
 
5x FS Buffer 
 
4µl 
0.1M DTT 
 
1µl 
RNAseOUT RNAse inhibitor (40 U/µl) 
 
1µl 
Superscript III reverse transcriptase 
(200 U/µl) 
 
1µl 
Incubated at 50ºC for 90 minutes, and then at 85ºC for 20 minutes. 1 unit 
of RNAseH (NEB) was added, followed by incubation at 37ºC for 20 
minutes. 
 
 
The first strand cDNA was quantified with the Quant-L7VV'1$$VVD\.LW
(Invitrogen), and stored at -20ºC. All regenerating samples were frozen at 
72 hours post amputation. 
 
2.2.11 Cloning of Smed_Tert cDNA and discovery of isoforms 
TERT protein sequences from multiple species were aligned with the sexual 
S.mediterranea genome assembly using tBLASTn, and the highest 
homology was found on the negative strand in Contig v31.000666. 
Putative exons surrounding the site of the blast hit were predicted using 
Genscan (http://genes.mit.edu/GENSCAN.html) and two ESTs were 
mapped to the genomic region within the predicted transcript. EST 
accession number ec1.13248.001(Robb et al., 2008) ORFDWHVRQWKH¶SDUW
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RI WKH F'1$ ZKLFK DSSHDUV WR FRQWDLQ DOVR D SDUW RI WKH ¶ 875 ZKLOH
PL08003A2F11(Zayas et al., 2005) ZDVPDSSHGWRWKH¶SDUWRIWKHF'1$
ZLWKDSDUWRIWKH¶875$VHWRISULPHUVZHUHGHVLJQHGWRDPSOLI\QHDUO\
the full length of the ORF from the cDNA in both strains (forward: 
TERT_F7; reverse: TERT_R), the PCR conditions are listed as follows: 
 
Total reaction volume: 50µl  Cycling conditions 
Reagent Final 
concentration 
Step Temperature Duration 
5x HF Buffer 
(Finnzymes) 
 
1x 1 98ºC 2 min 
2mM dNTP 
 
0.2mM 2 98ºC 12 sec 
Primer:    
TERT_F7  
(10µM) 
 
300nM 3 59ºC 20 sec 
Primer:   
TERT_R (10µM) 
 
300nM 4 72ºC 90 sec 
cDNA 
 
1ng/µl Repeat Step 2-4 36 Times 
Phusion 
polymerase 
(Finnzymes) 
 
0.06U/µl 5 72ºC 5 min 
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Deionised water 
 
Fill to 50µl  
 
The amplified products were cloned into pCR2.1 TOPO vectors, colonies 
were selected with 50µg/ml of kanamycin and blue-white screening in the 
presence of X-gal (20 mg/ml in DMSO). Positive colonies were randomly 
picked and inserts of different lengths were sequenced for the detection of 
isoforms. UTR sequence at both ends was confirmed by ¶ DQG ¶ RACE 
with the FirstChoice RLM-RACE Kit (Ambion) (see section 2.2.17 and 
2.2.18). 
 
2.2.12 Quantitative reverse transcription PCR 
qRT-PCR was performed with the first strand cDNA described above using 
the Brilliant qPCR master mix (Agilent), all reactions were incubated at 
95ºC for 10 minutes, followed by 40 cycles of 95ºC for 15 seconds, 
annealing temperature for 20 seconds, and 72ºC for 20 seconds. The 
transcription level of an internal control gene cystatin was used in each 
sample to standardise the template concentration. Each experiment was 
done in triplicate, with a pool of tRNA from 5 worms per replicate. Primers 
for each reaction are listed as follows:  
 
Amplifying target 
 
Primers Annealing 
temperature 
Primer 
Concentration 
(nM) 
 
All Smed_Tert 
isoforms 
TERT_qPCR_F3 
 
 
54ºC 
300 
TERT_qPCR_R3 300 
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Alt Region I +ve 
isoforms 
TERT_qPCR_AltI_F1 
 
 
54ºC 
450 
TERT_qPCR_AltI_R1 
 
450 
 
Alt Region I ±ve 
isoforms 
TERT_qPCR_AltI_F2 
 
 
51ºC 
200 
TERT_qPCR_AltI_R2 
 
200 
 
Alt Region II +ve 
isoforms 
 
TERT_qPCR_AltII_F1 
 
 
55ºC 
300 
TERT_qPCR_AltII_R1 
 
300 
 
cystatin  
(internal control) 
Cys_qPCR_F 
 
 
55ºC 
300 
Cys_qPCR_R 
 
300 
 
Category 1 cells 
Smedwi-2_F 
 
 
55ºC 
300 
Smedwi-2_R 
 
300 
 
Category 2 cells 
NB.21.11e_F 
 
 
55ºC 
300 
NB.21.11e_R 
 
300 
 
Category 3 cells 
Agat1_F 
 
 
56ºC 
300 
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Agat1_R 
 
300 
 
 
2.2.13 Whole mount in-situ hybridisation of Smed_Tert mRNA 
The experiment was preformed as previously described (Umesono et al., 
1997) with modifications (Nogi and Levin, 2005, Gonzalez-Estevez et al., 
2009). 
 
2.2.13.1  ?ǯ -DIG labelled probe 
¶-DIG labelled antisense probe was produced from the primary PCR 
product for double-stranded RNA synthesis described in section 2.2.1 (with 
the TERT_F2/ TERT_R primer set). A secondary PCR was done with the 
TERT_F2/Uni_T7_3¶ primer set (using the same conditions as the primary 
PCR) to attach a 751$SRO\PHUDVHELQGLQJVLWHVSHFLILFDOO\RQWKH¶HQG
of the primary PCR product. Single-stranded antisense probe was produced 
by in vitro transcription of the secondary PCR product, using the following 
procedures: 
Total reaction volume: 10µl  Procedure 
Reagent Final 
concentration 
Incubated at 37ºC for 8.5 hours. 
10x transcription 
buffer (Roche) 
 
1x Added 2 units of TURBO DNAse 
(Ambion), incubated at 37ºC for 
30 minutes. 
 
20mM rNTP 1x Filled to 35µl with water, and 
added with 5µl of 4M Lithium 
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chloride 
 
Secondary PCR 
product 
 
35ng/µl Precipitated with 150µl of EtOH 
at     -20ºC overnight. 
 
RNAseOUT RNAse 
inhibitor 
(Invitrogen) 
 
1U/µl Centrifuged at 12,000 x g for 30 
minutes, supernatant removed. 
T7 RNA polymerase 
(Roche) 
 
4U/µl Pellet washed with 1ml of 70% 
EtOH, then resuspended in 20µl 
of resuspension buffer by 
heating at 65ºC for 10 minutes. 
 
RNAse-free water 
 
fill to 10µl Quantified on a gel as described 
in section 2.2.1. 
  
2.2.13.2 Fixation and bleaching of whole planarian samples 
Samples used in this experiment include intact, regenerating, and gamma-
irradiated worms of both strains. All regenerating samples were cut into 
head, middle, and tail pieces, and allowed to regenerate for 72 hours. 
 
Worms were killed with K\GURFKORULFDFLGLQ+ROWIUHWHU¶VVROXWLRQ on 
ice for no more than 5 minutes, and then fixed with Carnoy solution (60% 
ethanol, 30% chloroform, 10% glacial acetic acid) for 2 hours on a shaker 
at 4°C. Samples were left in 100% methanol at -20°C for at least one 
hour, followed by bleaching with 6% hydrogen peroxide in methanol for 
approximately 20 hours under a cold lamp at room temperature. 
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2.2.13.3 Whole mount in situ hybridisation 
Bleached worms were hydrated using a series of 70%, 50%, and 30% 
HWKDQROLQ+ROWIUHWHU¶VVROXWLRQHDFKIRUPLQXWHVDW&7KHZRUPV
were permeabilised with PBSTx (0.1% TritonX-100/PBS) for 30 minutes at 
&DQGWKHQZLWKǋJPORI3URWHLQDVH. LQ3%67[IRU-12 minutes at 
37°C (the duration of Proteinase K treatment was determined by the size 
RI WKH VDPSOHV 7KHZRUPVZHUH ULQVHG LQ+ROWIUHWHU¶V VROXWLRQDQG
IL[HGZLWK3)$LQ+ROWIUHWHU¶Vsolution for one hour at 4°C, followed 
E\ZDVKLQJLQ+ROWIUHWHU¶VVROXWLRQIRURQHKRXUDW&7RUHPRYHDQ\
discolouration, the worms were incubated in 0.1M TEA pH7.6 for 15 
minutes at room temperature; this step was repeated with fresh TEA, 
followed by adding ǋO of acetic anhydride to the TEA and shaking at 
room temperature for 15 minutes. This addition was repeated with another 
ǋORIDFHWLFDQK\GULGHDQGWKHVDPSOHVZHUHLQFXEDWHGIRUPLQXWHVDW
room temperature. The worms were washed in PBS for 15 minutes at room 
temperature and incubated in ǋOof pre-heated prehybridisation buffer 
at 56°C for at least one hour on a rocker inside a Techne Hybridiser HB-1D 
oven. 7KH ¶-DIG-labelled probe ZHUH DGGHG WR ǋO of hybridisation 
buffer to a final concentrDWLRQRIQJǋO, and then denatured at 72°C for 
10 minutes and chilled on ice for 2 minutes. The prehybridisation buffer 
was replaced by the hybridisation buffer containing the probe, followed by 
hybridisation at 56°C for 20 hours. 
 
The post hybridisation solutions (PostHyb1, PostHyb2, Posthyb3, PostHyb4, 
PostHyb5, PostHyb6, Buffer I, and Buffer II) were freshly made, and 
PostHyb solutions 1-6 were pre-warmed at 56°C before use. The samples 
were rinsed three times with PostHyb1 solution, transferred to a 6 well 
plate, and washed in 3ml of PostHyb1 solution for 15 minutes at 56°C. The 
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samples were subsequently washed in 3ml of PostHyb 2-4 for 10 minutes 
each at 56°C, and then twice in 3ml of PostHyb5 and PostHyb6 for 30 
minutes at 56°C. The worms were washed twice in Buffer I for 10 minutes 
at room temperature, and then transferred to a 24 well plate and blocked 
with Buffer II for 1 hour at room temperature. The samples were incubated 
with ǋOof 1:2000 anti-DIG-AP antibody (Roche) in Buffer II for 3 hours 
at room temperature, and then rinsed twice in Buffer I, incubated twice in 
Buffer I for 10 minutes, and incubated overnight in Buffer I at 4°C. 
 
Following the incubation, the samples were washed twice in Buffer I for 10 
minutes at room temperature, and then incubated in the TMN solution in 
dark for 5 minutes at room temperature. Staining was developed with 
NBT/BCIP (Roche) in TMN (ǋOof NBT/BCIP solution per 1ml of TMN) in 
dark at room temperature. The development was stopped by washing in 1x 
PBS and fixed in 4% PFA in PBS for one hour at room temperature. The 
samples were rinsed with PBS and washed with a series of ethanol in PBS 
(30%, 50%, 70% for 5 minutes, 100% for 30 minutes, and then 70%, 
50%, 30% for 5 minutes) to reduce the background. The worms were 
washed in PBS and mounted onto glass slides in 70% glycerol/PBS and 
observed on a Zeiss Discovery V8 stereomicroscope, images were taken 
using an Axio Cam MRC camera. 
 
Two irradiation control probes were hybridised separately in this 
experiment, these include a neoblast-specific marker Smed-HistoneH2B at 
DZRUNLQJ FRQFHQWUDWLRQ RI  QJǋO and an end-differentiated neuronal 
marker Smed-GluR at 0.18 QJǋO. 
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2.2.14 Anti-phosphorylated histone H3 ser10 
immunohistochemistry 
The worms were fixed and bleached as described in section 2.2.13, and 
then washed in a series of 75%, 50%, and 25% methanol in PBSTx (0.3% 
TritonX-100 in PBS) for 10 minutes each at room temperature. The worms 
were washed twice in PBSTx for 10 minutes before they were blocked with 
1% BSA in PBSTx for 2 hours at room temperature. The samples were 
incubated with an anti-phosphorylated histone H3 serine 10 rabbit 
monoclonal primary antibody (Upstate Millipore, diluted 1:600 in 1% 
BSA/PBSTx) for 43 hours at 4°C. The samples were washed in 1ml of 
PBSTx for 8 hours at room temperature, with replacement of PBSTx with 
fresh solution every 30 minutes. The samples were then blocked with 1% 
BSA in PBST for 1 hour at room temperature, and incubated with an Alexa 
Fluor 568-conjugated goat anti-rabbit secondary antibody (Molecular 
Probes, diluted 1:1000 in 1% BSA/PBSTx) in dark at 4°C for 14-16 hours. 
The samples were washed for 4 hours in PBSTx in dark at room 
temperature, with the solution replenished every 30 minutes, followed by 
fixing overnight with 4% PFA in PBS in dark at 4°C. The samples were 
washed twice in PBS for 10 minutes at room temperature and mounted in 
1:2 Slowfade antifade (Invitrogen) diluted in 50% glycerol/PBS. 
 
Staining was visualised on a Leica MZ16F fluorescent stereomicroscope 
with a Leica DFC 300Fx camera (Leica Lasertechnik, Heidelberg), positive 
cells were counted using the ImageJ software. 
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2.2.15 Metaphase chromosome spread 
This method was modified from Lamatsch et al, 1998 (Lamatsch et al., 
1998). Planarian samples (6 worms per sample) were amputated and 
treated with 0.065% colchicine at 56 hours post cut for 16 hours. The 
regenerating tissues, including the post-blastema regions, were cut off 
from the rest of the body and hypotonically shocked with 1M sodium 
citrate for 20 minutes at room temperature. The tissues were then fixed in 
Carnoy solution (ethanol: acetic acid 3:1, differs from the one used for in-
situ hybridisation) at 4ºC for 30 minutes, followed by cell dissociation with 
55µl of 45% acetic acid at room temperature for 16 hours. The cell 
suspensions were centrifuged at 200g for 5 minutes, and the supernatant 
was dropped onto chilled slides (pre-treated by soaking in chilled 70% 
ethanol and polished with paper towel before use). The slides were 
immediately covered with slips and snap-frozen on dry ice, the coverslips 
were removed before the slides thawed. The slides were allowed to dry on 
the bench, and then soaked in Carnoy solution for 5 minutes, followed by 
air-dry and staining with DAPI in PBS in dark for 20 minutes. The DAPI 
solution was rinsed off with deionised water and the slides were mounted 
in PBS and observed with a Nikon eclipse 80i fluorescent compound 
microscope. Images were taken with a Hamamatsu ORCA-ER digital 
camera. 
 
2.2.16 ¶5DSLGDPSOLILFDWLRQRIF'1$HQGV5$&( of Smed_Tert 
and Smed_Pot1 
The WHPSODWH F'1$ XVHG LQ ¶ 5ACE was synthesised with the same 
procedure as the first strand cDNA described in section 2.2.10. The 
attached OligodT18, adapted from the OligodT12 of the FirstChoice RLM-
RACE kit (Ambion), at the end of each transcript provides binding sites for 
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a nested reverse PCR primer set, which when paired with a set of gene-
specific nested primers, can amplify the region between currently known 
sequence of the gene and the ¶end of the transcript. PCR reactions for 
Smed_Tert and Smed_Pot1 are listed as follows: 
Outer PCR 
Total reaction volume: 50µl  Cycling conditions 
Reagent Final 
concentration 
Step Temperature 
 
Duration 
Tert Pot1 
5x HF Buffer 
(Finnzymes) 
 
1x 1 98ºC 98ºC 2 min 
2mM dNTP 
 
0.2mM 2 98ºC 98ºC 12 sec 
Primer:    
TERT_¶2XWB)
327B¶2XWB)
(10µM) 
 
300nM 3 58ºC 58ºC 20 sec 
Primer:   
¶2XWBR (10µM) 
 
300nM 4 72ºC 
 
72ºC 60 sec 
cDNA 
 
1ng/µl Repeat Step 2-4 34 Times 
Phusion 
polymerase 
(Finnzymes) 
0.06U/µl 5 72ºC 72ºC 2 min 
 65 
 
 
Deionised water 
 
Fill to 50µl  
 
Inner PCR 
Total reaction volume: 50µl  Cycling conditions 
Reagent Final 
concentration 
Step Temperature 
 
Duration 
Tert Pot1 
5x HF Buffer 
(Finnzymes) 
 
1x 1 98ºC 98ºC 2 min 
2mM dNTP 
 
0.2mM 2 98ºC 98ºC 12 sec 
Primer:    
TERT_¶,QQB)
327B¶,QQB)
(10µM) 
 
300nM 3 58ºC 58ºC 20 sec 
Primer:    
¶,QQB50 
 
300nM 4 72ºC 
 
72ºC 60 sec 
Outer PCR 
product 
 
1µl total Repeat Step 2-4 34 Times 
Phusion 
polymerase 
0.06U/µl 5 72ºC 72ºC 2 min 
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(Finnzymes) 
 
Deionised water 
 
Fill to 50µl  
 
The inner PCR products were gel-extracted, cloned into pCR 2.1 TOPO 
plasmids (Invitrogen), and confirmed by sequencing. 
 
2.2.17 5¶RACE of Smed_Tert and Smed_Pot1 
'LIIHUHGIURPWKH¶5$&(WKH¶5$&(UHTXLUHVUHPRYDORISKRVSKDWHVDQG
WKHFDSVWUXFWXUHDWWKH¶HQGRIHDFKP51$IROORZHGE\OLJDWLRQRIWKH¶
RACE adaptor to the end, which provides recognition sites for nested 
forward primers. Subsequent PCR amplifications with these primers, 
together with gene-specific reverse nested primers, allow the identification 
of unknown sequences between a IUDJPHQWRIDJHQHDQGLWV¶HQG 
 
Reactions were preformed with reagents supplied in the FirstChoice RLM-
RACE kit (Ambion). Total RNA was extracted from the worms as described 
in section 2.2.10. 1µg of the total RNA was treated with 2µl of Calf 
Intestine alkaline Phosphatase (CIP) in presence of 1x CIP Buffer in a 20µl 
reaction. The mixture was incubated at 37ºC for one hour, after which 15µl 
of ammonium acetate stop solution was added and the mixture was filled 
to 150µl with RNAse-free water. The RNA was purified with a phenol-
chloroform extraction, and precipitated with an equal volume of 
isopropanol on ice for 10 minutes. After centrifugation and washing with 
70% ethanol, the RNA was resuspended in 4µl of 1x Tobacco Acid 
Pyrophosphatase (TAP) Buffer, and incubated with 1µl of TAP at 37ºC for 
one hour. 7KH WUHDWHG 51$ ZDV OLJDWHG ZLWK QJ RI WKH ¶ 5$&( 51$
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Adaptor using 2µl of T4 RNA ligase in presence of 1X Ligase Buffer, in a 
10µl reaction at 37ºC for one hour. 
 
Reverse transcription of the ligated total RNA was done using the 
SuperScript III reverse transcriptase (Invitrogen), with the following 
procedures: 
Reagents 
 
Quantity 
50µM Random Decamers (from the 
RACE kit) 
 
1µl 
10mM dNTPs 
 
1µl 
Ligated total RNA 
 
2µl 
RNAse-free distilled water 
 
Fill to 13µl 
Incubated at 65ºC for 5 minutes, chilled on ice. 
 
5x FS Buffer 
 
4µl 
0.1M DTT 
 
1µl 
RNAseOUT RNAse inhibitor (40 U/µl) 
 
1µl 
Superscript III reverse transcriptase 
(200 U/µl) 
1µl 
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Incubated at 50ºC for 60 minutes, and then at 85ºC for 20 minutes. 1 unit 
of RNAseH (NEB) was added, followed by incubation at 37ºC for 20 
minutes. 
 
 
The cDNA was not quantified, and was used directly for the outer RACE 
PCR. The PCR reactions are listed as follows: 
Outer PCR 
Total reaction volume: 50µl  Cycling conditions 
Reagent Final 
concentration 
Step Temperature 
 
Duration 
Tert Pot1 
5x HF Buffer 
(Finnzymes) 
 
1x 1 98ºC 98ºC 2 min 
2mM dNTP 
 
0.2mM 2 98ºC 98ºC 12 sec 
Primer:    
TERT_¶2XWB5
327B¶2XWB5
(10µM) 
 
300nM 3 60ºC 60ºC 20 sec 
Primer:   
¶2XWB)µM) 
 
300nM 4 72ºC 
 
72ºC 60 sec 
cDNA 1µl total Repeat Step 2-4 34 Times 
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Phusion 
polymerase 
(Finnzymes) 
 
0.06U/µl 5 72ºC 72ºC 2 min 
Deionised water 
 
Fill to 50µl  
 
Inner PCR 
Total reaction volume: 50µl  Cycling conditions 
Reagent Final 
concentration 
Step Temperature 
 
Duration 
Tert Pot1 
5x HF Buffer 
(Finnzymes) 
 
1x 1 98ºC 98ºC 2 min 
2mM dNTP 
 
0.2mM 2 98ºC 98ºC 12 sec 
Primer:    
TERT_¶,QQB5
327B¶,QQB5
(10µM) 
 
300nM 3 58ºC 62ºC 20 sec 
Primer:    
¶,QQB)0 
 
300nM 4 72ºC 
 
72ºC 40 sec 
Outer PCR 1µl total Repeat Step 2-4 34 Times 
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product 
 
Phusion 
polymerase 
(Finnzymes) 
 
0.06U/µl 5 72ºC 72ºC 2 min 
Deionised water 
 
Fill to 50µl  
 
The inner PCR products were gel-extracted, cloned into pCR 4 TOPO 
plasmids (Invitrogen), and confirmed by sequencing. 
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CHAPTER 3: TELOMERE LENGTH AND ITS 
MAINTENANCE IN S.mediterranea 
 
3.1 Introduction 
3.1.1 Finding the telomeric repeat unit in S. mediterranea 
The presence of (TTAGGG)n terminal sequence in Polycelis tenuis (Joffe et 
al., 1996) has suggested that the telomere of the closely related S. 
mediterranea also consists of the same tandem repeats. This hypothesis is 
supported by large tandem (TTAGGG)n repeat regions located at one end 
of several contigs or trace reads in the S. mediterranea genome. Table 
3.1.1 contains a list of currently identified contigs and reads which contain 
possible telomeric sequences. 
 
Type Name Possible telomeric region 
Trace read ujm06g02.b1 263 ± 643 bp 
Trace read uki42d10.b1 176 ± 556 bp 
Trace read SAAE-adi73e04.g1 76 ± 323 bp 
Trace read SAAE-agm29d05.g1 71 ± 330 bp 
Trace read SAAA-ajg75g07.b1 29 ± 254 bp 
Trace read SAAA-ajg80e01.b1 33 ± 246 bp 
Contig v31.000477 1 ± 175 bp 
 
Table 3.1.1 ± Possible telomeric regions in S. mediterranea genomic 
contigs and trace reads. 
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3.1.2 Confirming telomeric sequence by the Terminal Restriction 
Fragment (TRF) analysis 
Experiments were designed to measure the length of (TTAGGG)n repeats 
in the genome and to confirm that these repeats belong to chromosomal 
ends. A restriction endonuclease which recognises and cuts a specific 
pattern of six nucleotides LH D ³-cutWHU´ should cut on average every 
4096bp (46, calculated from the probability of a specific recognition site 
sequence arisen by random chance). Assuming every additional 6-cutter 
enzyme splits the average fragment size by a half, treating gDNA with a 
combination of five 6-cutters will theoretically produce fragments with an 
average size of 256bp (46 divided by 2(5-1)). The selected enzymes do not 
cut (TTAGGG)n repeats, and therefore the size of the restriction fragments 
visualised by the (TTAGGG)n probe in southern hybridisation should be 
similar to the real size of these repeat sequences (Harley et al., 1990). In 
order to confirm that the signal on the blot was not produced by large 
internal (TTAGGG)n repeats, the gDNA was treated with the Bal-31 
exonuclease (Blackburn and Challoner, 1984)ZKLFKGHJUDGHVERWK¶DQG
¶ WHUPLQL RI GXSOH['1$ SULRU WR WKH HQGRQXFOHDVH GLJHVWLRQ Telomeric 
sequences are sensitive to the degradation while internal repeats should 
not be affected by this treatment. The use of 6-cutters allows detection of 
known internal sequences which can be used as a control for the effect of 
Bal- FOHDYDJH ,Q FRQWUDVW WR WKH ³4-cXWWHUV´ZKLFK VHYHUHO\ IUDJPHQWV 
internal sequences, the 6-cutters were selected to produce a 2787bp band 
of nanos gene which should not be sensitive to Bal-31 treatment. 
3.1.3 Telomere length dynamics in sexual and asexual strains of 
S. mediterranea 
In the absence of reproductive cells, the long term survivability of an 
asexual lineage relies, in theory, on a somatic stem cell population which 
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has an indefinite proliferative life-span. Since telomere integrity is essential 
for the viability of a cell, it can be hypothesised that the telomere lengths 
of the stem cells in asexual worms are properly protected from erosion 
during cell cycling, in order to ensure the proliferative capacity and 
genome stability of the cells over an evolutionary timescale. The 
maintenance is likely to be achieved by telomerase due to its common 
presence across eukaryotic kingdoms. The presence of the enzyme is 
known to be linked to proliferative cells in normal non-immortalised 
somatic human cells (Masutomi et al., 2003), and previous work has also 
shown telomere extension events, as well as increase in TERT expression 
and telomerase activity in S phase cells in human and yeast (Masutomi et 
al., 2003, Wellinger et al., 1993). Therefore telomere maintenance in the 
stem cell population in S. mediterranea is likely to be linked to events 
involving massive cell divisions. Previous studies have shown peaks in 
proliferative cells in regenerating planarians, with the first mitotic 
maximum occurring at approximately 6 hours post amputation and a 
higher second peak occurring at 2-3 days post cut (Baguñà, 1976b, Saló 
and Baguña, 1984). The rapid cell divisions during regeneration could 
cause substantial telomere erosion unless a proper telomere maintenance 
mechanism is present. Since regeneration plays an essential part of 
asexual reproduction in S. mediterranea, mechanisms should be present to 
counteract the telomere erosion during this reproductive event. If 
telomerase is involved in the maintenance mechanism, it should be 
functional during S phase in cycling cells. Therefore telomere extension 
events should be concentrated during regeneration, when massive cell 
cycling occurs. It is likely that telomeres of an asexual worm are 
periodically replenished in its life cycle, through fission and subsequent 
regeneration. This theory is based on the fact that no functional germline is 
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present in asexual worms (Saló, 2006), and somatic stem cells therefore 
should possess the immortal property of germ cells. 
 
The discovery of nanos positive primordial germ cells in the asexual strain 
(Sato et al., 2006, Wang et al., 2007b, Handberg-Thorsager and Salo, 
2007) suggests an alternative model, in which the asexual worms are 
facultatively sexual, and telomeres are maintained in the primordial germ 
cells, which can be give rise to somatic stem cells with replenished 
telomeres following fertilisation or parthenogenesis. Lack of reproductive 
organs in asexual worms indicates that if this mechanism exists, no genetic 
material is exchanged between strains, and fertilisation is confined within 
hermaphroditic individuals. 
 
The sexual strain of S. mediterranea does not reproduce by 
fission/regeneration, and possesses a complete germline reproductive 
system. Therefore it is uncertain whether a well maintained somatic 
telomere is required for long-term survivability of the population. Although 
the life span of sexual S. mediterranea has not been previously studied, 
early work in various sexually reproducing relative triclad species have 
suggested a limited life expectancy in the sexual worms (Child, 1914, 
Haranghy and Balázs, 1964), a recent demographic study in sexual marine 
platyhelminthes has also seen a limited life span (Mouton et al., 2009). 
However sexual worms are also capable of clonal amplification in the 
laboratory by amputation, which suggests a stem cell population with high 
proliferative and self-renewal capacity. It is likely that the sexual strain 
also shares the same somatic telomere replenishing mechanism with the 
asexual worms after amputation, since the regenerated fragments are de 
facto juvenile worms with no mature germ cells and gonadopores, and 
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their somatic age may need to be reset to match their reproductive age. 
While for sexual worms without injuries, the somatic cells may age, 
limiting the life span of parents and giving space for offspring which 
contain more genetic variation. Since sexual worms do not self-induce 
injuries as the asexuals, their telomere maintenance should normally be 
concentrated in the germline instead of the soma. Telomeres in other 
multicellular organisms are well maintained in the germline (De Lange et 
al., 1990, Allsopp et al., 1992, Fiset and Chabot, 2001), consistent with 
the fact that telomerase is highly expressed during gametogenesis (Mantell 
and Greider, 1994, Yashima et al., 1998) and/or embryogenesis 
(Schaetzlein et al., 2004). It is likely that an un-injured homeostatic sexual 
worm uses the same telomere maintenance strategy as other sexual 
organisms (high in germline and low the soma), and after body 
fragmentation the telomere of the soma is reset. 
 
In this project, the telomere length of both strains was measured at 
different stages of the life cycle. Additionally, the effect of regeneration on 
telomere length in both strains was also investigated. To obtain the size of 
telomeres with more precision, the gDNA was digested with a mixture of 
three 4-cutters, of which the cutting sites are theoretically closer to the 
tandem repeats than those of the 6-cutters due to their frequent cutting 
nature, which in addition to the smaller average internal fragments (64 
bp), produce purer terminal restriction fragments after FIGE separation. 
 
In addition to the TRF analysis, a qPCR based method (Cawthon, 2002) 
was used to measure the copy number of telomeric repeat sequence in the 
genome. Primers used for amplifying telomeric sequence usually form 
staggered dimers due to the tandem repeat nature of this region. The 
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modified oligonucleotides used in this technique were designed to have a 
mismatch to the genomic telomeric sequence every six bases but perfect 
complementarity DW WKH ODVW ILYH ¶ bases. This design results in a 
PLVPDWFKHG¶ HQGZKHQ WKH WZRSULPHUV DUH K\EULGLVHG SUHYHQWLQJ WKH
formation of dimer products. The first VL[ EDVHV DW WKH ¶ HQG RI ERWK
primers do not hybridise to the genomic DNA, therefore the amplified PCR 
product will not act as primers in later cycles. When the qPCR reaction is 
finished at the log phase, the relative telomere length of each sample can 
be determined as a factor by which the sample differs from a reference 
sample in the ratio of the telomeric copy number to the copy number of a 
single gene (ie. the T/S value) (Cawthon, 2002). This technique was 
applied to confirm the difference in the telomere length between the 
strains. 
 
3.1.4 Telomere maintenance activities in both strains of S. 
mediterranea 
Presence of telomerase enzyme activity was assayed with the Telomere 
Repeat Amplification Protocol (TRAP) (Kim et al., 1994). This method is 
based on incubation of a synthetic substrate of telomerase, TS primer, with 
the total protein extract, followed by a PCR amplification to detect the 
elongation of the TS primer by the telomerase present in the total protein. 
In the presence of telomerase activity, PCR amplification with the TS and 
RP primer set of the kit produces a ladder of products with 6 base 
increments, starting at 50bp. An internal positive control for the PCR 
reaction (primer K1 and template TSK1), which produces a 36bp product, 
is included in the PCR reaction mix to identify false-negative results caused 
by Taq inhibitors (illustrated in Figure 3.1.1). The activity was compared 
between intact and regenerating worm samples in both strains. The link 
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between telomerase activity and proliferative cells was also examined by 
TRAP assay with worms treated with 100 Gy of gamma irradiation, which 
was previously shown to remove cells with proliferative capacity in 
planarians (Bardeen and Baetjer, 1904). 
 
 
Figure 3.1.1 ± Schematic of the telomere repeat amplification 
protocol (TRAP) assay. Incubation of TS primer with total protein extract 
causes the extension of the primer if telomerase is present. The extended 
TS primer can be detected by PCR amplification using TS and RP primer 
set, which gives a ladder of products with increments corresponding to the 
size of a tandem repeat unit (ie. 6bp for (TTAGGG)n). 
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3.2 Results 
3.2.1 Confirmation of tandem repeat sequence at chromosome 
ends 
The (TTAGGG)n signals on the blot was sensitive to the treatment with 
Bal-31 exonuclease. The mean sizes of the signals, defined as ƶ2'L
ƶ2'L/L (see section 2.2.5), in samples treated with Bal-31 for various 
durations are listed in Table 3.2.1. Decrease in both the top and average 
sizes of the signals were observed as the duration of the treatment 
increased. In contrast, the band produced by the nanos probe stayed at a 
constant size of 2787bp (see Figure 3.2.1).  
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Figure 3.2.1 ± Bal-31 digestion of sexual gDNA followed by 6-cutter 
TRF analysis. The effect of the exonuclease on telomeric repeat sequence 
(TTAGGG)n was compared to its effect on a gene sequence located 
internally (Nanos). UD: untreated gDNA; Un-Bal: gDNA digested with the 
6-cutters without prior treatment with Bal-31; 30-240 Min: various 
durations of Bal-31 treatment. 
 
 
Duration of Bal-31 treatment Mean signal length (kb) 
0 minute 9.73 
30 minutes 8.58 
60 minutes 7.86 
120 minutes 6.07 
240 minutes 4.48 
 
Table 3.2.1 ± Mean sizes of (TTAGGG)n signals in Bal-31 treated samples. 
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3.2.2 Telomere length dynamics in asexual and sexual strains of 
S. mediterranea 
The telomeres in the asexual strain (see Figure 3.2.2a) range from 10kb to 
35kb depending on the period of time since last fission or induced 
regeneration event. Samples extracted on the 7th day since last fission had 
a length distribution between 20 and 35kb, with a mean at 28.03kb and a 
standard deviation (s.d.) of the mean at 0.71kb (n=10). This is 
significantly longer (t-test, two tailed, p=0.0199) than telomeres in 
samples extracted after 3 months post fission, which had a length 
distribution between 10 and 35kb, with a mean at 25.98kb and an s.d. at 
0.60kb (n=10). Following three consecutive artificially induced 
regenerations in samples which had not undergone fission for between 3 
and 6 months, the telomere length distributes between 20 and 40 kb 
(mean=26.93kb, s.d.=1.48kb, n=10), which is significantly longer (t-test, 
two tailed, p=0.0335) than that of the same individual samples before 
regeneration (10 ± 31kb, mean=22.67kb, s.d.=1.75kb, n=10). 
 
Telomere length in the sexual strain (see Figure 3.2.2b) was similar to 
previous findings in human and mice, with a decrease as a function of the 
age of the individuals; and the difference between individual worms was 
higher than that in the asexuals. Using sexual worms which were allowed 
to grow without events of induced regeneration, it was found that despite 
the heterogeneity between individuals, older worms have consistently 
shorter telomeres than younger samples. New-born hatchlings had a mean 
length at 21.20kb (s.d.=1.67kb, n=7), while the 1-year-old samples had a 
mean at 17.25kb (s.d.=2.03kb, n=7) and the 3-year-old samples at 
11.06kb (s.d.=1.40kb, n=6). The lower ends of the distribution in the 3-
year-old samples were shorter than the 2kb limit of the FIGE program, and 
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therefore the actual mean can be shorter than that calculated from the blot. 
In contrast to the telomere reset in the asexuals, induced regeneration had 
an opposite effect on the telomere length in sexual worms. Samples after 
three consecutive regeneration events had a telomere length between 2 ± 
20kb (mean=11.58kb, s.d.=1.49kb, n=10), which is significantly shorter 
(t-test, two tailed, p=0.00679) than that of the same individuals before 
regeneration (13 ± 22kb, mean=17.55kb, s.d.=1.33kb, n=10). All asexual 
and sexual samples regenerated eyes and pharynx by Day 7 post 
amputation, the rate of regeneration is ubiquitous among the samples and 
does not show correlation with the telomere length. 
 
The relative telomere lengths in both strains measured by the qPCR 
technique were consistent with the results from the TRF analysis. After 
standardising with the single copy NB.21.11e gene, the telomeric copy 
number of the newly regenerated asexual fission sample was 1.44 times 
greater (three replicates of a batch of 5 worms, s.d.=0.0921) than that of 
the reference sample, which is an asexual worm grown for 3 months since 
last fission. In contrast, the 1-year-old sexual sample had a telomere copy 
number 78% of the reference (three replicates of a batch of 5 worms, 
s.d.=0.0655). 
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Figure 3.2.2 ± Strain-specific telomere length dynamics in S. 
mediterranea. (A) Reset of telomere length in the asexual strain after 
ILVVLRQ DQG LQGXFHG UHJHQHUDWLRQ 8' 8QGLJHVWHG J'1$ 7KH ³ GD\V´
VDPSOHV UHSUHVHQW ZRUPV QHZO\ UHJHQHUDWHG IURP ILVVLRQ ZKLOH WKH ³
PRQWKV´Uepresent samples with no recent fission events; Int: Intact worm 
samples; Reg: Samples after 3 consecutive regeneration events. (B) 
Telomere erosions with age and after regeneration in the sexual strain. NB: 
New-born hatchlings; 1yo: 1 year old; 3yo: 3 year old; Int: Intact worm 
samples; Reg: Samples after 3 consecutive regeneration events. 
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Figure 3.2.3 ± Relative telomere length measured by qPCR. The copy 
number of telomere repeats in newly fissioned asexual S. mediterranea 
samples was compared with that in 1-year-old sexual samples. An asexual 
sample extracted at three months since last fission event was used as the 
standard reference. Three individual samples were included in each strain. 
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3.2.3 Presence of telomere maintenance activity in S. 
mediterranea proteome 
6HYHUDOPRGLILFDWLRQVIURPWKHPDQXIDFWXUHU¶VSURWRFROIRUWKH75$3DVVD\
were required for optimal results in S. mediterranea. The incubation step 
was prolonged to 45 minutes from the recommended 30 minutes. As 
shown in Figure 3.2.4, incubation with more than 0.05µg of total protein 
produced an extra band, of which the intensity increased with the amount 
of total protein. Bands for the extended TS products also diminished as the 
total protein increased, indicating the presence of a TRAP inhibitor in the 
total protein. This inhibitory effect can be removed by a phenol-chloroform 
extraction step between the TS incubation and the PCR amplification, 
suggesting that the inhibitor targets Taq polymerase instead of telomerase. 
The duration of the elongation step of the PCR reaction was changed to 90 
seconds, for a total of 35 cycles. The TRAP activity appeared to be 
sensitive to RNAse, since reactions in the absence of RNAse inhibitor failed 
to produce elongated products. Several brands of the RNAse inhibitors 
were tested, including the RNAseOUT (Invitrogen), Protector (Roche), 
RNAsin and RNAsin Plus (Promega), it was found that the RNAsin Plus 
provided the best protection against the RNAse present in the total protein 
extract. Previous work of Ruman Rahman (unpublished) favoured the use 
of Roche Taq polymerase, which also produced better results in this project 
than the Bioline equivalent. 
 
The TRAP assay detected the elongation of the TS primer after incubating 
with the total protein extract of S. mediterranea. The elongation occurred 
in a similar manner to the HeLa cell extract, a telomerase positive sample 
used as a control, which adds six bases to the substrate progressively. 
Differences in the activity could be observed between intact and 
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regenerating samples (Figure 3.2.5a and 3.2.5b), total proteins from 
regenerating worms produced longer TS products, as indicated by the size 
of the amplified bands. Inter-strain differences in intact samples were not 
noticeable. The regenerating sexuals had slightly fainter bands compared 
to the asexuals, this difference may be more apparent in Figure 3.2.5b 
where twice the amount of total protein was used in each sample. 
Appreciable difference in the size of the longest amplified products was not 
observed between strains. 
 
Total protein extracted from worms seven days after the treatment with 
100Gy of gamma irradiation produced very little TRAP activity compared to 
the untreated controls.  
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Figure 3.2.4 ± Presence of TRAP assay inhibitor in the total protein 
extract. PCR products for extended TS primers are fuzzy and do not 
increase by 6bp as seen in the HeLa cell extract positive control. 
Incubation with more than 0.05µg of the total protein reduced the 
presence of extended TS primers on the gel. These inhibitory effects can 
be removed by a phenol-chloroform extraction before the PCR step. 
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Figure 3.2.5 ± TRAP assay showing up-regulation of telomerase 
activity during regeneration. Reactions were performed with (A) 0.5µg 
or (B) 1.0µg of total protein per sample (Samples in A and B were 
independently extracted). Int: Intact worm sample; Reg: Regenerating 
sample, 72hr after amputation. For each sample, total protein was 
extracted from 3 worms (~8mm each). 
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Figure 3.2.6 ± Telomerase activity after removal of neoblasts with 
100Gy of gamma irradiation. IRR: Irradiated samples; Un-IRR: Un-
irradiated controls. Samples were extracted 7 days post treatment. 
 
3.3 Discussion 
The Bal-31 sensitivity of the (TTAGGG)n signals in the TRF analysis 
suggested that these signals were produced by the real terminal restriction 
fragments. The band produced by the internal nanos gene did not change 
in size after treatment. The disappearance of the signal in the 120 and 240 
minute time points is likely due to the lower yield of ethanol precipitation 
as a result of decreased DNA content in the samples after the prolonged 
exonuclease degradation. The results of TRF analysis with 4-cutters have 
also ruled out the existence of internal (TTAGGG)n repeats larger than 2kb, 
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the lower end of the FIGE gel, since no signals of constant sizes were 
present between different samples. These results have validated the TRF 
technique as a method for studying telomere dynamics in S. mediterranea. 
 
The 6-base-pair manner in which the TS substrate was elongated by the 
total protein extract is similar to that by the telomerase positive protein 
extract. In addition, the sensitivity of this elongation to RNAse suggests 
the requirement for RNA components in the protein which processed the 
substrate. These results strongly suggest the presence of telomerase 
holoenzyme in S. mediterranea proteome. 
 
The negative correlation between telomere lengths and age in sexual 
samples indicates that the homeostatic level of telomere maintenance is 
insufficient to prevent age-related telomere erosion. The fact that the new-
born hatchlings of sexual worms have long telomeres while the parents 
which gave rise to these offspring have short telomeres suggests that 
telomere length is prevented from erosion in the germline, or the length 
resets during sexual reproduction, either in gametogenesis or 
embryogenesis. In contrast, rapid telomere attrition observed in 
regenerated sexual samples indicates insufficient telomere maintenance in 
somatic cells. Since mature germ cells apoptose during regeneration 
(Wang et al., 2007b), a majority of the TRF signals in regenerated samples 
should correspond to the somatic telomere lengths after rapid cell 
divisions. The difference between germline and somatic maintenance is 
similar to common multicellular telomere models such as human and 
mouse (LaBranche et al., 1998, Fiset and Chabot, 2001, Wagner et al., 
2011). A different scenario to the common models is that the germ cells in 
planarians are thought to be differentiated progenies of the somatic stem 
 91 
 
cells (Wang et al., 2007b). It is not certain whether there is a sub 
population of somatic stem cells with a high telomere maintenance level, 
which is pre-committed to the germ cell lineage, or if all somatic stem cells 
have the potency to form germ cells, and the telomere maintenance is only 
up-regulated after this commitment. 
 
The telomere length reset occurs in asexual worms during regeneration, in 
contrast to the erosion of telomeres in the sexuals. The shorter telomeres 
observed in asexual samples with no recent regeneration events suggest 
insufficient telomere maintenance during homeostatic cell turnover, a 
characteristic shared between the strains. The periodic occurrence of 
regeneration events in asexual worms through reproduction by fission 
indicates that their telomeres are regularly replenished. The homogeneity 
of telomere length distribution after regeneration indicates that the 
maintenance event occurs in a majority, if not all, of body stem cells 
instead of a certain sub-population. Therefore the facultative sexual model 
discussed in section 3.1.3 is unlikely, since the maintenance event should 
occur in somatic cells instead of the nanos positive primordial germ cells. 
This somatic telomere maintenance circumvents the end-replication 
problem which limits the proliferation capacity of somatic cells, and 
therefore ensures the long-term survivability of the organism without 
passage through the germline. Evolution of this somatic maintenance is 
essential for adaptation to the agametic asexual life history. 
 
The increase in TRAP activity during regeneration correlates with the boost 
of mitotic cell counts, which suggests a link between proliferation and 
telomerase regulation, possibly in the same cell cycle stage manner as 
seen in human and yeast, with the highest telomerase expression and 
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activities in S phase (Masutomi et al., 2003, Wellinger et al., 1993). The 
TRAP activity in intact samples displays the basal level of telomere 
maintenance during homeostatic turnover, this level is not sufficient to 
prevent telomere erosion, which is evident in the TRF analysis in both 
strains. The size of the telomerase-extended product increased in 
regenerating samples of both strains, indicating that both strains are 
capable of enhancing telomerase processivity during regeneration. The 
sexual regenerating sample had fainter bands compared to the asexual 
sample, suggesting lower telomerase activity in sexual regenerating 
worms. It is not clear whether the increase in TRAP activity in regenerating 
sexuals was due to the nanos-positive primordial germ cells which may 
have high maintenance but are low in number, or by all somatic stem cells 
which enhance telomerase to a less extent compared to the asexual stem 
cells. Although the significance of this inter-strain difference is yet to be 
assayed, the consequence of this difference is the fundamentally different 
telomere dynamics between the strains during regeneration. 
 
In summary, the telomeric repeat unit in S. mediterranea has been 
confirmed to be (TTAGGG)n, the telomere length dynamics indicate a 
somatic telomere reset mechanism which is present in regenerating 
asexual worms but absent in the sexuals. Telomerase activity has been 
identified in this organism, and appears to be confined to radiation-
sensitive stem cells. Both strains are capable of increasing telomerase 
processivity during regeneration; however the telomerase activity differs 
between the strains, causing telomere length reset in the asexuals and 
rapid telomere erosion in the sexuals. 
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CHAPTER 4: DISCOVERY AND CHARACTERISATION 
OF Smed_TERT, THE CATALYTIC SUBUNIT OF 
TELOMERASE IN S.mediterranea 
 
4.1 Introduction 
4.1.1 Discovery of Smed_Tert, the reverse transcriptase subunit 
of telomerase 
Results from the previous chapter have provided evidence for the presence 
of telomerase activity in S. mediterranea. In order to study how cells 
control telomere maintenance and compare telomere biology between the 
strains, it is necessary to find the genes encoding the telomerase 
holoenzyme. Attempts to identify the homolog for the telomerase RNA 
subunit have failed because of the poor sequence similarity between 
species. However preliminary work by Daniel Felix has identified a short 
sequence similar to the catalytic reverse transcriptase subunit of 
telomerase (TERT, referred to as EST2 in Saccharomyces cerevisiae) of 
Schizosaccharomyces pombe in the planarian genome using TBlastN. 
Further bioinformatic analyses using gene prediction software GENSCAN 
and BLAST with multiple EST databases were performed, and the full 
length of the gene was identified and confirmed with reverse transcription-
PCR and sequencing. The sequence of the protein was aligned with TERT in 
multiple organisms and most of the conserved sequence motifs were 
mapped, including those located in the reverse transcriptase domain and 
the telomerase specific region. Sequencing has also identified several 
alternatively spliced variants of the gene (details in Chapter 5). 
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4.1.2 Expression patterns of Smed_Tert in the sexual and 
asexual strains 
With the sequence of Smed_Tert identified, in-situ hybridisation was 
performed in intact, regenerating, and irradiated samples of both strains 
ZLWKD¶-DIG-labelled RNA probe targeting at a consensus sequence of all 
known Smed_Tert isoforms. As a follow-up from the TRAP experiment in 
irradiated animals in Chapter 3, qRT-PCR on the transcription level of 
Smed_Tert in irradiated samples was also performed to test for 
consistency with the previous protein assay. 
 
4.1.3 Inhibition of Smed_Tert expression by RNA interference 
Double stranded RNA was artificially synthesised from a 601bp consensus 
region between all Smed_Tert transcripts, this spans the Motif C, D, and E 
of the reverse transcriptase domain. The dsRNA was injected into the gut 
branches of the worms from an area anterior to the pharynx, and the 
effect of the RNAi was confirmed by a TRAP assay on samples collected 
after 15 weeks of treatment. Control samples were injected with the same 
amount of dsRed dsRNA. The asexual strain was used in this experiment 
due to the consistent telomere lengths between individuals. TRF analyses 
were performed in samples collected as the RNAi progressed. Some 
samples were withdrawn from the RNAi after 18 weeks of injections and 
their telomere lengths were measured after 12, 21, and 33 weeks of 
telomerase restoration. All TRF analyses were done on regenerating 
samples for maximum difference between erosion and reset. The relative 
telomere lengths between the RNAi samples, the controls, and the 
telomerase-restored samples were confirmed by qPCR with the same 
technique described in Section 3.1.3. 
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4.1.4 Proliferation assays on Smed_Tert RNAi samples 
The TRAP results from the previous chapter have shown a strong link 
between telomerase activity, proliferation and proliferative cells. In order 
to understand the effect of the Smed_Tert inhibition on proliferation, whole 
mount immunohistochemistry was conducted with an antibody against 
phosphorylated serine 10 in histone H3, which was previously shown to 
specifically mark cells in M phase (Gurley et al., 1978, Paulson and Taylor, 
1982, Hendzel et al., 1997, Newmark and Sánchez Alvarado, 2000). It is 
necessary to separate the effect of the absence of Smed_TERT protein with 
the effect of short telomere on proliferation, and therefore the 
immunostaining was done on samples with two different durations of RNAi 
treatment, 15 and 46 weeks. Samples treated with 15 weeks of RNAi had 
little residual Smed_TERT activity while their telomeres were on average 
10kb longer than those in the 46 weeks samples (shown in Section 4.2.3). 
The number of cells stained positive with the marker was compared to the 
number in the controls injected with dsRed dsRNA for the same duration. 
Counts in intact samples indicate the basal level of cell division, while 
counts in regenerating samples show the ability of the worms to increase 
proliferation in response to injuries. 
 
 
 
4.2 Results 
Whole mount in situ hybridisations were conducted with help from Farah 
Jaber Hijazi, while the phosphorylated histone H3 ser10 
immunohistochemistry was performed in collaboration with Chen Chen. 
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4.2.1 Discovery of Smed_Tert gene in S. mediterranea genome 
TBlastN and multi-species alignment using human, mouse, and fission 
yeast TERT protein sequences produced a 216bp homologous sequence hit 
on the negative strand of Contig v31.000666 (42404 ± 42189bp) of the 
genome assembly (see Figure 4.2.1). This sequence encodes a part of the 
canonical reverse transcriptase domain of Smed_TERT, which locates at 
the C-terminal half of the protein in all studied organisms. Genscan 
software had predicted a 1362aa protein located between 59776 ± 5711bp 
of the contig, and the nearest ESTs mapped to the predicted transcript on 
each side of the TBlastN hit were used as primer targets for PCR 
amplification from cDNA. The 668bp long EST PL08003A2F11 (Zayas et al., 
2005) ORFDWHV ¶ to the TBlastN hit on the predicted transcript, and 
contains a 75bp overlap with the hit. While the 722bp long ec1.13248.001 
(Robb et al., 2008) ZDVPDSSHG¶to the hit. A forward primer (TERT_F7) 
was designed from ec1.13248.001 and a reverse (TERT_R) from 
PL08003A2F11, which produced multiple PCR amplicons from cDNA 
synthesised from both the sexual and asexual strains (details of different 
amplicons are included in Chapter 5 and Figure 5.2.1). Sequencing of the 
longest cloned amplicon revealed an 1833bp long partial transcript which 
shows high homology to TERT protein in BlastX (organism of the highest 
hit: Strongylocentrotus purpuratus, e = 3 x 10-14). When the unamplified 
regions in both ESTs were included into the transcript, an in-frame STOP 
VLWHZDV LGHQWLILHG FORVH WR WKH¶ HQGRI 3/$)ZLWKESRI¶ 
8757KH67$57VLWHZDVLGHQWLILHGDVWKHFORVHVW$7*VLWHLQIUDPH¶WRD
6723VLWHDWWKH¶HQGRIHFZLWK3ESRI¶8757KHOHQJWKV
of UTRs were later FRQILUPHGE\¶DQG¶5$&( 
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In summary, Smed_Tert is located at 51308 ± 34955bp of Contig 
v31.000666 in the S. mediterranea genome, with the full-length transcript 
1895bp in length, which is translated into a 625aa protein. The locations of 
exons and introns are listed in Table 4.2.1. 
 
Exon/Intro
n 
 
Location on 
v31.000666 
Size 
(bp
) 
 Exon/Intro
n 
 
Location on 
v31.000666 
Size 
(bp
) 
Exon 1 51269..5130
8 
40 Exon 9 44172..4426
8 
97 
Intron 1 50958..5126
8 
311 Intron 9 44126..4417
1 
46 
Exon 2 50835..5095
7 
123 Exon 10 44037..4412
5 
89 
Intron 2 50787..5083
4 
48 Intron 10 42530..4403
6 
150
7 
Exon 3 50702..5078
6 
85 Exon 11 42450..4252
9 
80 
Intron 3 50660..5070
1 
42 Intron 11 42405..4244
9 
45 
Exon 4 50570..5065
9 
90 Exon 12 42187..4240
4 
218 
Intron 4 47497..5056
9 
307
3 
Intron 12 38675..4218
6 
351
2 
Exon 5 47428..4749
6 
69 Exon 13 38612..3867
4 
63 
Intron 5 47389..4742 39 Intron 13 35569..3861 304
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7 1 3 
Exon 6 47293..4738
8 
96 Exon 14 35483..3556
8 
86 
Intron 6 47250..4729
2 
43 Intron 14 35438..3548
2 
45 
Exon 7 47153..4724
9 
97 Exon 15 35184..3543
7 
254 
Intron 7 44555..4715
2 
259
8 
Intron 15 35123..3518
3 
61 
Exon 8 44315..4455
4 
240 Exon 16 34955..3512
2 
168 
Intron 8 44269..4431
4 
46    
Table 4.2.1 ± Locations of exons and introns of Smed_Tert gene on 
Contig v31.000666. 
 
 
Multi-species alignment of TERT had identified most of the conserved 
sequence motifs of known functions (Figure 4.2.2 and Appendix A), 
LQFOXGLQJWKHFDQRQLFDOUHYHUVHWUDQVFULSWDVHUHJLRQ$%¶&'DQG
E) and the telomerase-specific signatures (GQ, CP, QFP, and T). The RNA 
binding domain was identified by BlastP. High homology was found from 
Motif QFP to E, however the N-terminal part of the protein contains 
sequences highly diverged from other species and both Motif GQ and CP 
were hardly aligned. Motif DAT could not be identified by this alignment. 
Unlike Trt-1 in C. elegans, the full length Smed_TERT contains a well 
aligned QFP motif. 
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Figure 4.2.1 ± Gene and protein annotations of Smed_TERT. (A) 
Location of Smed_Tert in the S. mediterranea genome assembly version 
3.1, introns were shrunk to 1/5 of their actual sizes for the sake of this 
illustration. 7KH³7%ODVW1+63´PDUNV WKHUHJLRQRI WKHKLJKHVWKRPRORJ\
between multiple species (for alignment see Figure 4.2.2 and Appendix A). 
(B) The 1923bp full length transcript of Smed_Tert, with the two closest 
ESTs mapped on either side of the TBlastN hit site. (C) Protein structure of 
Smed_TERT. The multi-species conserved motifs include the canonical 
UHYHUVHWUDQVFULSWDVHUHJLRQ$%¶&'DQG E) and the telomerase-
specific signatures (GQ, CP, QFP, and T). Motif CP cannot be precisely 
mapped due to low sequence similarity. TRBD: Telomerase RNA Binding 
Domain. 
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Figure 4.2.2 ± Multi-species comparison of TERT protein structure. 
6HTXHQFH¶of the GFP motif in S. mediterranea has low homology to TERT 
in other species and the motifs could not be precisely mapped (for details 
of the sequence alignment see Appendix A). 
 
4.2.2 Expression pattern of Smed_Tert 
qPCR on the total transcription level of all Smed_Tert isoforms (using 
TERT_qPCR_F3/R3 primer set) showed an average of 95.31% decrease (t-
test, two tailed, unequal variance, p=0.00701) 7 days after treatment with 
100Gy of gamma irradiation, comparing to the mock-irradiated controls 
(see Figure 4.2.3a). The experiment was done in three replicates on 
batches of five worms. 
 
Whole mount in-situ hybridisation of Smed_Tert showed expression in the 
testes, ovaries, and gonadopore of mature sexual worms (n=7) (see Figure 
4.2.3b-d). This pattern is sensitive to irradiation, and regressed in samples 
fixed at 72 hours post amputation. Expression could also be observed in 
primordial reproductive cells in juvenile sexual worms (n=7), which also 
disappeared when irradiated and during regeneration. In asexual samples 
a trans-parenchyma pattern, concentrated in an area surrounding pharynx 
and the posterior mid-line, was observed (n=7). The expression could also 
be eliminated by irradiation. In 72 hour post-amputation regenerating 
samples the pattern did not differ from intact samples. The trans-
parenchyma pattern may also exist in the sexuals, however this could not 
be distinguished from the strong background in these samples. 
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Figure 4.2.3 ± Expression pattern of Smed_Tert in both strains. (A) 
Transcription level the Smed_Tert in asexual worms 7 days after 
irradiation. (B) Whole mount in-situ hybridisation of Smed_Tert in mature 
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sexual, juvenile sexual and asexual worms. All irradiated samples were 
treated with 85Gy of gamma-irradiation, and fixed on the 7th day post-
treatment. Irradiation control marker Smed-H2B represents a cell 
population sensitive to irradiation, while Smed-GluR represents a 
population which is insensitive. (C) High magnification image of 
Smed_Tert expression in the periphery of mature testes. (D) Ventral view 
of a mature sexual sample showing Smed_Tert expression in the ovaries. 
(E ± F) Magnified view of Smed_Tert expression in homeostatic and 
regenerating sexual mature samples, showing diminishing expression of 
the gene in germ cells as they apoptose.  (E) Anterior region between the 
photoreceptors and pharynx. (F) Trunk region close to the pharynx. Scale 
bar: 0.5mm.  
4.2.3 Inhibition of Smed_Tert expression by RNAi 
TRAP assay on regenerating asexual samples extracted after 15 weeks of 
injections with Smed_Tert dsRNA showed observable decrease in 
telomerase activity (see Figure 4.2.4a). This is accompanied by 
progressive reductions in telomere lengths, as well as diffusion in the 
distribution of lengths, as shown in Figure 4.2.4b. The calculated mean 
telomere lengths, indicated by the white dotted lines, in samples collected 
as the RNAi treatment prolongs, were analysed in Figure 4.2.4c. The 
reduction showed a good correlation with the duration of RNAi (R2 = 
0.9345), and occurred at a rate of approximately 290bp per week. After 
removing the RNAi, the telomeres remained at the mean length when the 
withdrawal occurred (week 18). As the recovery progresses the length 
distribution was restored to the homogeneity seen in the dsRed controls, 
however the mean lengths remained unchanged. Three individual samples 
were measured at each time point. 
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Telomere lengths measured by qPCR also showed relative decreases in 
Smed_Tert RNAi treated worms (see Figure 4.2.4d). With the same 
reference DNA as used in Chapter 3, samples treated with 11 weeks of 
RNAi had a mean T/S value of 1.57 (s.d. of mean = 0.388), while the 36 
and 45 weeks samples had 0.66 and 0.28 (s.d.=0.216 and 0.0161), 
respectively. The control samples, treated with 45 weeks of dsRed RNAi, 
had a mean T/S of 2.55 (s.d.=0.0750). Samples recovered after 21 weeks 
of RNAi withdrawal from week 18 had a mean T/S of 0.81 (s.d.=0.392). 
Three individual samples were measured at each time point. 
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Figure 4.2.4 ± Effect of Smed_Tert RNA interference on the 
telomerase activity and telomere length. (A) TRAP activity in 72 hour 
post-amputation regenerating samples after 15 weeks of RNAi. Two 
independent protein extractions were performed for each RNAi-treated 
group, with 3 worms in each extraction. (B) Progressive shortening of 
telomere in samples injected with Smed_Tert dsRNA. After removing RNAi 
(Lane r12, r21 and r33, which correspond to the number of week post 
removal) the telomere is stabilised to the length at the time of withdrawal 
(week 18). White dotted lines represent the mean telomere length of each 
VDPSOHGHILQHGDVƶ2'Lƶ2'L/LDVSUHYLRXVO\GHVFULEHG(Harley et al., 
1990). Each lane is a representative of a triplicate experiment using three 
individual worms. (C) Mean length of telomere versus the length of RNAi 
treatment. An average erosion rate of approximately 290bp per week is 
observed. (D) qPCR analysis for the relative telomere lengths in worms 
treated with Smed_Tert RNAi (T11, T36 and T45) or dsRed control (ds45). 
r21 refers to samples taken after 21 weeks of recovery from RNAi since the 
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withdrawal in week 18. Three individual samples were measured at each 
time point. 
 
4.2.4 Effect of Smed_Tert RNAi on cell proliferation 
The phosphorylated histone H3 serine 10 immunostaining had found no 
significant difference in mitotic cell counts between the Smed_Tert RNAi 
treated samples and the dsRed controls in all sample groups including 
intact worms on Week 15 and regenerating worms reaching their two 
mitotic peaks on Week 46 (n=10, p=0.562, 0.371 and 0.148, respectively; 
t-test, two tailed, unequal variance) (see Figure 4.2.5). 
 
 
 
Figure 4.2.5 ± Mitotic cells counted from the phosphorylated 
histone H3 ser10 immunohistochemistry. (A) Examples of the 
immunofluorescence signal in Week 15 intact samples. (B) Cell counts 
shown as ratios to the counts in the Smed_Tert RNAi samples in each 
individual sample group. Raw cell counts are shown below. Ten individual 
samples were included in each time point. Int: intact; 6hr and 72hr: 
regenerants reaching their first and second mitotic peak, respectively. 
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4.3 Discussion 
4.3.1 Smed_Tert gene, transcript, and protein 
The 1895bp transcript of Smed_Tert is encoded by its gene which spans 
16.354kb in the genome. The presence of enormously sized introns and 
some small exons (for example, the 61bp Exon 13 is flanked by a 3512bp 
¶LQWURQDQGD3ES¶LQWURQ have been an obstacle to the mapping of 
ESTs to the genome. Fortunately the Genscan software was able to 
produce a predicted transcript to which the two ESTs could be mapped, 
and the beginning and the end of the ORF happened to be contained in 
each EST. The two ESTs originate from separate databases, indicating the 
discrepancies between different sequencings and assemblies of the S. 
mediterranea transcriptome. 
 
Sequencing of cloned amplicons from TERT_F7 and TERT_R have revealed 
various alternatively spliced isoforms of Smed_Tert, which will be shown 
and analysed in detail in Chapter 5. Some isoforms appeared to lack Exon 
4, 5, and 6, which encodes for the QFP and T motifs of the telomerase 
RNA-binding domain (TRBD). This domain is conserved across eukaryotic 
kingdoms (Xia et al., 2000), however it is shortened in C. elegans due to 
the absence of the QFP motif (Meier et al., 2006). S. mediterranea has 
naturally occurring isoforms of Smed_Tert with full-length or truncated 
TRBDs, indicating a possible branching point of TERT evolution in 
invertebrates with short TRBD. The QFP motif has been previously shown 
to interact with the telomerase RNA subunit (Friedman and Cech, 1999), 
together with Motif CP and T, and is essential for telomerase assembly (Xia 
et al., 2000, Lai et al., 2001, Bosoy et al., 2003). However the lack of QFP 
domain in C. elegans does not impair the function of its telomerase. The 
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functions of the naturally occurring Smed_Tert isoforms in S. mediterranea 
are yet to be studied. We hypothesise that the isoforms with short TRBD 
possess different target specificity, or may act as a competitive inhibitor of 
the full-length isoform for telomere binding. 
 
4.3.2 Cell specificity of Smed_Tert expression 
Consistent with the elimination of TRAP activity after irradiation shown in 
Chapter 3, transcription of Smed_Tert three days after lethal irradiation 
decreased to less than 5% of that in mock-irradiated controls, providing 
further evidence for the exclusive expression of Smed_Tert in proliferative 
cells. Whole mount in-situ hybridisation showed high expressions in testes, 
ovaries, and gonadopore in the sexual strain. High magnification image 
suggests specific expression in the periphery of the testes, resembling the 
pattern of a previously reported gene hnRNPA2, which is enriched in 
spermatogonial cells and early spermatocytes (Wang et al., 2010). 
Regression of Smed_Tert-expressing testes in 72hr regenerating sexual 
worms resembles the regression pattern of T-plastin, which is expressed 
specifically in the spermatocytes and spermatids (Zayas et al., 2005, Wang 
et al., 2007b). In contrast with nanos which labels all cells committed to 
the germline property, including precursor cells, and the expression 
pattern does not regress to the same extend as T-plastin during 
regeneration (Sato et al., 2006, Wang et al., 2007b, Handberg-Thorsager 
and Salo, 2007). It seems likely that Smed_Tert is up-regulated only in 
proliferating gamete-producing germ cells in mature sexual worms, and 
these cells undergo programmed cell death during regeneration (González-
Estévez and Saló, 2010). In sexual juveniles the expression is high in the 
primordial germ cells, which is similar to the pattern of nanos positive 
germline cells. In the 72hr regenerating juvenile samples these cells lose 
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Smed_Tert expression. It is therefore likely that the germline primordial 
cells are high in telomerase when they proliferate during development of 
reproductive organs, and become relatively quiescent and low in 
telomerase during regeneration. Although previous studies have not shown 
the proliferation pattern of nanos positive cells during different stages of 
regeneration, it can be hypothesised that proliferation of these cells is 
restored after 7 days post amputation, when the T-plastin positive cells 
begin to reappear in mature worms (Wang et al., 2007b). In summary, it 
is proposed that the telomerase in sexual planarians is highly expressed 
only in rapidly proliferating cells with germline properties, and these cells 
are either removed (T-plastin+) or do not divide (nanos+) during 
regeneration. Double in-situ hybridisations with Smed_Tert and T-plastin, 
as well as Smed_Tert and nanos in various time points of regenerating 
sexual planarians, together with the locations of phospho-histone H3 Ser10 
positive cells in these samples, are required to test this theory. 
 
With strong background hybridisation it is not currently possible to observe 
the expression of Smed_Tert in somatic stem cells in sexual samples. 
Future TRAP and qPCR analysis with sexual worms treated with nanos 
RNAi, as well as optimisation of Smed_Tert in-situ hybridisation, are 
required for further understanding of the difference in the telomerase 
activity between the germline and somatic stem cells. 
 
In the asexual strain high expression of Smed_Tert was found in somatic 
stem cells concentrated around the pharynx and the posterior mid-line. In 
contrast with the pattern in sexual worms, expression was not found in 
nanos positive presumptive germ cells in the asexuals and appeared to be 
present ubiquitously in somatic stem cells. This supports the observation 
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from the TRF analysis, which suggests that telomeres of all stem cells are 
replenished, as opposed to maintenance in a confined sub-population. 
Current in-situ results in regenerating samples did not show obvious 
Smed_Tert up-regulation, however the transcription level of the gene will 
be studied in more precision with qPCR in Chapter 5. 
 
4.3.3 Inhibition and restoration of Smed_Tert transcription 
Inhibition of Smed_Tert transcription by dsRNA injection has reduced the 
level of telomerase activity sufficiently to cause rapid erosion of telomeres 
and lack of telomere reset during regeneration. However the RNAi treated 
animals did not develop the Tert knockout phenotypes observed in 
Xenopus laevis and mouse, which include impaired anterior-posterior axis 
formation and homeotic transformation (Park et al., 2009). No physical 
phenotypes or defects in regeneration were observed in the knocked-down 
samples, possibly due to the presence of residual Smed_TERT protein 
which is inevitable with the RNAi technique. In the Week 57 samples with a 
mean telomere length of less than 10kb, the worms grew and regenerated 
normally, suggesting that the mortality stage has not yet been reached. 
 
An unanticipated result was observed in samples recovering from 
Smed_Tert RNAi, where the mean telomere lengths were reset to a new 
size determined by the length of telomeres at the time of withdrawal. 
Restoration of telomerase activity did not increase the mean telomere 
length, but only restores the homogeneity of the length distribution after 
regeneration. This result raises a question about how a cell decides the 
target telomere length to which its telomerase needs to reach during 
regeneration, and how the lower part of TRF length distribution in pre-
regeneration samples disappears after regeneration. One may speculate 
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that the level of telomere maintenance between individual cells differs 
depending on their relative telomere lengths. Assuming a certain sub-
population of stem cells always has the longest telomere in the body, and 
other types of stem cells have a way to detect the relative length of their 
telomeres to the longest, and enhance telomere maintenance accordingly. 
This enhancement may involve increase in transcription of full-length 
Smed_Tert, reduction in telomerase inhibitors, improved telomerase 
assembly in the Cajal body, better recruitment of telomerase in late S 
phase, and/or post-translational regulations of telomerase (see Chapter 1 
for reviews of these mechanisms). 
 
Another possible explanation for the length distribution dynamics during 
regeneration is that the enhanced telomerase activity is enough to prevent 
telomere erosion in the cell population with longest telomeres. Both stem 
cells and end differentiated cells with short telomeres may be subjected to 
programmed cell death, as suggested by the TUNEL assay in regenerating 
planarians in previous studies (Hwang et al., 2004, Pellettieri et al., 2010), 
and the body is replaced by new progeny of the long-telomere stem cells. 
A first burst of cell death occurs at 1-4 hours post amputation, followed by 
the first mitotic peak at 4-6 hours; the second peak of both cell deaths and 
cell divisions occur at approximately 3 days post-amputation. These 
coinciding events support the replacement theory of the telomere reset. 
The fact that cells with restored telomerase activity after RNAi removal 
remained with stable short telomeres is also in favour of the hypothesis 
that telomerase prevents erosion instead of elongates telomeres in the cell 
population with long telomeres. Although no TUNEL patterns in 
regenerating sexual planarians have been published to date, the cellular 
events during regeneration in sexual worms should be similar to those in 
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the asexuals. It is therefore difficult to explain the increased heterogeneity 
in telomere length distribution after regeneration in the sexuals with the 
replacement theory, since the TRF result suggests against the 
predominance of fresh long-telomere progeny cells in regenerated sexual 
worms. 
 
Experiments can be designed to test the enhanced-maintenance theory 
and the replacement theory (not necessarily mutually exclusive). 
Optimisation of Smed_Tert in-situ hybridisation or generation of stable 
transgenic lines with reporter-tagged Smed_TERT is required for 
localisation and quantitative studies. Double in-situ with Smed_Tert and 
telomeric PNA probes should give information about the level of telomere 
maintenance in cells with different telomere lengths, while double staining 
with TUNEL and telomeric PNA should reveal whether cells with short 
telomeres are major subjects of apoptosis during regeneration. 
 
4.3.4 Smed_TERT and cell cycle progression 
The data in Figure 4.2.5 indicates that knock-down of Smed_Tert 
transcription, and the resulting insufficiency of Smed_TERT protein, do not 
affect the basal proliferation counts in planarians; and at a mean telomere 
length of approximately 10kb, the cells can enter proliferation normally 
without arrest at cell cycle checkpoints. These results are consistent with 
the lack of observable phenotypes and unaffected regeneration capacities 
in RNAi samples (experiment concluded in Week 60). 
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CHAPTER 5: NATURALLY OCCURRING VARIATIONS 
OF Smed_TERT 
 
5.1 Introduction 
5.1.1 Alternative splicing isoforms of Smed_Tert in other 
organisms 
Transcription variants of Tert have been previously identified in human 
(Kilian et al., 1997), with alternative splice sites located solely in the 
reverse transcriptase region of the gene. One of the variants (K7HUWĮ) 
utilises an alternative splice acceptor site in Exon 6, resulting in an in-
frame deletion of a part of the conserved Motif A, and possesses a 
dominant negative function when ectopically expressed in telomerase-
positive human cells (Colgin et al., 2000, Yi et al., 2000). Similar inhibitory 
properties were also found in experimentally mutated human TERT 
proteins with single amino acid substitutions such as D712A (Motif A) and 
D868/9A (Motif C) (Zhang et al., 1999). In addition to the Į variant, 
K7HUWǃ lacks Exon 7 and 8 which locate at the linker region between Motif 
A and B¶ (Kilian et al., 1997). Exclusion of this region results in a 
premature STOP codon in Exon 10, which truncates the protein. Both 
K7HUWǃ and K7HUWĮǃ (which lacks both regions) have no catalytic activities 
and do not act as dominant negative inhibitors (Yi et al., 2000). The other 
isoforms currently identified contain intronic insertions, for which no 
detailed functional studies have been published. 
 
A recent study in a chicken MDV lymphoma-derived MSB-1 T-cell line has 
identified 27 alternatively spliced variants of chTert (Amor et al., 2010). 
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Five of those variants are in-frame exon-exclusion transcripts, which were 
shown to be non-functional by TRAP assay when reconstituted in vitro. The 
remaining 22 variants possess premature STOP codons, 19 of which have 
the codon more thaQ ES XSVWUHDP RI WKH ¶ VSOLFH MXQFWLRQ DQG ZHUH
therefore predicted as targets for nonsense-mediated decay (NMD). The 
most abundant prematurely stopped variant was confirmed as a NMD 
target by RNAi against the NMD pathway. The low telomerase activity in 
normal T-cells was shown to be a result of predominant expression of in-
frame variants. Increase in the telomerase activity during induced 
lymphomagenesis coincides with a proportional increase in the level of 
constitutively spliced chTERT over other variants, together with an increase 
in the prematurely stopped inactive variants over the in-frame inactive 
variants. 
 
5.1.2 Smed_Tert isoforms in S. mediterranea 
Cloning and sequencing of RT-PCR products from cDNA synthesised from 
both strains have so far identified two alternatively spliced sites in 
Smed_Tert. The 255bp Alternative Region I contains Exon 4, 5, and 6 of 
the constitutively spliced transcript, which encode for the conserved Motif 
QFP and a part of Motif T of the TRBD domain. While the 298bp Alternative 
Region II is in the RT domain and consists of Exon 11 and 12, which covers 
WKHOLQNHUUHJLRQEHWZHHQ0RWLI$DQG%¶DVZHOODV0RWLI%¶, C, and a part 
of Motif D (see Figure 5.2.1c). Isoforms lacking Alt Region I appeared to be 
in-frame, whereas those lacking Alt Region II possess a premature STOP 
codon due to frame shift. 
 
In order to test whether transcriptional control plays a role in the up-
regulation of telomerase and telomere length lengthening during 
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regeneration observed in Chapter 1, qPCR primers were designed to 
specifically amplify isoforms which contain (+ve primers), or do not contain 
(-ve primers), the alternative regions. A +ve primer set has at least one of 
the oligonucleotide located within the alternative site, while a ±ve primer 
set has one of the oligonucleotide sitting across the splicing boundary at its 
¶HQGT3&5UHDFWLRQVZHUHSHUIRUPHGLQLQWDFWDQGUHJHQHUDWLQJVDPSOHV
of asexual, juvenile sexual, and mature sexual strains. 
 
For the total transcription level of all Smed_Tert isoforms, a primer set 
TERT_qPCR_F3/R3 was designed to amplify a region found in all isoforms. 
7KHUHJLRQORFDWHVDWWKH¶HQGRIWKHWUDQVFULSWVDQGWKHUHIRUHWKH¶ELDV
nature of OligodT-based cDNA has a minimised effect, and the copy 
number of the amplicon corresponds to the real total level of Smed_Tert 
transcription in the sample. 
 
5.2 Results 
5.2.1 Currently identified alternatively spliced isoforms of 
Smed_Tert 
RT-PCR using TERT_F7 and TERT_R produced multiple products with 
various sizes in all samples (see Figure 5.2.1b). A region between 1kb to 
2kb on the gel was cut and extracted, and the products from one individual 
worm of each strain were cloned separately into pCR2.1 TOPO vectors 
(Invitrogen). Sequencing of the randomly picked positive colonies revealed 
the identity of different sized products as transcription variants of 
Smed_Tert given rise by alternative splicing. Isoform 1 has a PCR product 
size of 1833bp, it is the longest isoform and therefore is thought to be the 
constitutively spliced full-length transcript. Isoform 2 lacks the 255bp 
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Alternative Region I and its PCR product size is 1578bp. Isoform 3 lacks 
the 298bp Alternative Region II and the product is 1535bp in size. Isoform 
4 contains neither of the alternative regions and its product size is 1280bp. 
The ORF of each isoform was identified bioinformatically. Isoform 1 and 2 
are both in-frame and can be translated into 625aa and 540aa proteins, 
respectively. Both Isoform 3 and 4 contain a premature STOP codon in 
Exon 13 due to the frame-shift caused by the exclusion of Alternative 
Region II (see Figure 5.2.2), their ORF size are therefore drastically 
reduced and the proteins they encode are 353aa and 268aa, respectively. 
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Figure 5.2.1 ± Regions of alternative splicing in Smed_Tert and 
currently identified Smed_Tert isoforms. (A) Alternative Region I 
includes exon 4, 5 and 6, while Alternative Region II includes exon 11 and 
12. (B) RT-PCR products from both strains using the TERT_F7 and TERT_R 
primer set. The gel region between 1.25kb and 2kb was cloned and 4 
isoforms, lacking either or both Alt regions, were identified by sequencing. 
Isoform 3 and 4 have an alternative STOP site due to frame shift (see 
Figure 5.2.2). (C) Alt Region I locates at the QFP motif and a part of the T 
motif of the Telomerase RNA subunit Binding Domain (TRBD), Alt Region II 
is an essential part of the reverse transcriptase domain. 
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Figure 5.2.2 ± Alternative STOP site in Region II ±ve Smed_Tert 
isoforms. Isoform 3 and 4 have a premature STOP site (indicated by an 
asterisk) in exon 13 due to a frame shift caused by the exclusion of exon 
11 and 12 which truncates the reverse transcriptase domain of 
Smed_TERT (see Figure 5.2.1c). 
5.2.2 Single nucleotide variations between haplotypes 
Substitutions at the single nucleotide level were observed between 
different RT-PCR clones derived from an individual asexual worm. These 
mutations did not appear to be isoform-specific. The currently identified 
SNPs are listed in Table 5.2.1. 
Position 
(bp) 
Strain Nucleotide AA. 
Residue 
Abundance Haplotype 
 
179-180 
(Motif CP) 
Sexual GA I63 15/15 - 
Asexual GG V63 5/15 M1 & M2 
Asexual CA I63 10/15 S 
605 
(T-1 
linker) 
Sexual C I205 15/15 - 
Asexual T I205 15/15 M1/2 & S 
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635 
(Motif 1) 
Sexual T S215 15/15 - 
Asexual C S215 5/15 M1 & M2 
Asexual T S215 10/15 S 
 
837 
(2-A 
linker) 
Sexual C L282 15/15 - 
Asexual G V282 5/15 M1 & M2 
Asexual C L282 10/15 S 
 
1312  
(Motif D) 
Sexual A K440 12/15 - 
Asexual T I440 3/15 M1 
Asexual A K440 11/15 M2 & S 
 
1712 
¶
terminal) 
Sexual T S574 / NA 15/15 - 
Asexual G S574 / NA 3/15 M1 
Asexual T S574 / NA 12/15 M2 & S 
 
Table 5.2.1 ± Asexual strain-specific single nucleotide variations of 
Smed_Tert. Since the mutations are present only in certain RT-PCR 
clones, these clones are named ³Haplotype M´, with M1 carrying all the 
listed mutations, and M2 carrying all but the last two mutations. The clones 
with no amino acid changes from the sexual transcripts (ie. sexual-like) 
DUH QDPHG ³Haplotype S´ 7KH SUHPDWXUHO\ VWRSSHG LVRIRUPV GR QRW
cRQWDLQWKH6UHVLGXHDQGDUHPDUNHG³1$´LQWKHWDEOH 
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Figure 5.2.3 ± Schematic of currently identified full-length cDNA 
haplotypes.   
5.2.3 Transcription levels of the alternative isoforms 
All experiments in this section were done in triplicate, on batches of five 
worms per replicate. As shown in Figure 5.2.4a, the total copy number of 
all Smed_Tert transcripts showed an average of 2.73 fold increase 
(p=0.0182, T-test, two tailed, unequal variance) in asexual samples during 
regeneration. This pattern was not observed in the sexual strain, with no 
significant changes in the juvenile (1.22 fold increase, p=0.635) and 
mature (2.22 fold decrease, p=0.160) samples. 
 
Enrichment of Alt Region-containing isoforms in the asexual strain was 
observed during regeneration. The copy number of the Alt Region I-
positive isoforms (see Figure 5.2.4b) increased by 6.89 fold (p=0.00237) 
and the Alt Region II-positive isoforms (Figure 5.2.4c) increased by 8.50 
fold (p=0.0300). The copy number of these regions in the sexual juveniles 
did not change significantly (1.32 fold increase, p=0.542 and 1.01 fold 
increase, p=0.985 for Alt Region I and II, respectively), while a significant 
decrease was observed in the mature sexual samples in Alt Region II (2.14 
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fold decrease, p=0.0513) but not Alt Region I (1.30 fold decrease, 
p=0.519). 
 
The copy number of the Alt Region I-negative isoforms decreased in all 
analysed samples by an average factor of 1.29, 2.57 and 3.47 (p=0.0998, 
0.0927 and 0.00943) in asexual, sexual juvenile, and sexual mature, 
respectively. When analysed together with the Alt Region I-positive copy 
numbers (see Figure 5.2.4d), the positive/negative ratio of this region 
increased in all samples during regeneration by an average factor of 8.86, 
3.71 and 2.54 (p=0.0231, 0.0592 and 0.203), respectively. 
 
Various designs for the Alt Region II-negative primer set have failed to 
produce enough signal for detection, despite the use of extra template (a 
maximum of 100ng per 25µl reaction was tried). 
 
Figure 5.2.4 ± Quantitative PCR analysis of the transcription level of 
(A) the total Smed_Tert transcripts, (B) isoforms containing Alt Region I, 
(C) isoforms containing Alt Region II, and (D) the isoforms with and 
without Alt Region I in intact and regenerating samples of both strains. 
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Error bars display ±1 standard deviation. juv: juvenile; mat: mature. 
Three replicates of batches of 5 worms each were analysed in each sample, 
asterisks indicate groups with p-values < 0.03. 
 
5.3 Discussion 
5.3.1 Possible functions of Smed_Tert splicing isoforms 
A unique feature of Tert in S. mediterranea is the presence of an 
alternative splicing site in the conserved TRBD domain, in which splicing 
variations have not so far been discovered in other organisms. Previous 
studies using experimentally mutated or naturally occurring mutants in this 
region (Friedman and Cech, 1999, Lai et al., 2001, Yamaguchi et al., 2005, 
Xin et al., 2007b) have shown the importance of this region for telomerase 
activity and association of this region with susceptibility to acute myeloid 
leukaemia. Since the RNA subunit of telomerase has not been identified in 
this organism, it is not currently possible to study the functions of the 
splicing variants by in vitro reconstruction. Nevertheless, the increase in 
the positive-negative ratio of Alt Region I during regeneration does suggest 
the coincidental enrichment of full-TRBD isoforms with the enhancement of 
telomerase activity seen in the TRAP assay. This enrichment occurs in 
regenerating samples of both strains, suggesting a splicing regulation of 
telomerase in the stem cells. With preserved N-terminal and C-terminal 
sequences, it is possible that the Isoform 2, which carries a truncated 
TRBD and a complete RT domain, is capable of being recruited to the single 
stranded telomeres by protein-protein interactions, but has no telomere 
maintenance activities due to the absence of RNA template. Therefore the 
Isoform 2 may compete with the full-length Isoform 1 in telomere binding 
and exhibit an inhibitory effect on telomere maintenance. 
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The premature stop codon in isoforms lacking Alt Region II (Isoform 3 and 
4) is 30bp upsWUHDP RI WKH ¶ VSOLFH MXQFWLRQ ZKLFK LV VKRUWHU WKDQ WKH
50bp distance for the NMD pathway suggested by the previous chicken 
study (Amor et al., 2010). It is uncertain whether these isoforms are stable 
or subjects of the NMD pathway. Failure of the primer sets to amplify the 
isoforms lacking this region may due to the difficulty of designing primers 
across the splice boundary. Comparing the fold increase in the expression 
level between total Smed_Tert and Alt Region II-positive isoforms (Isoform 
1 and 2) during regeneration in asexual samples, Isoform 1 and 2 
increased by 8.50 fold while the total Smed_Tert only increased by 2.73 
fold. Therefore it is likely that the proportion of Isoform 3 and 4 in the total 
transcript is not negligible. If these isoforms are translated, the truncated 
RT domain and the absence of constitutive C-terminal structure in these 
proteins suggest they are non-catalytic, and may also be non-telomeric. 
They may function similarly to the previously studied human TERT which 
modulates Wnt dependent genes by acting as DFRIDFWRURI WKHǃ-catenin 
transcriptional complex in an RT-independent manner (Choi et al., 2008, 
Park et al., 2009). If these isoforms are targets of the NMD pathway, cells 
may use the splicing of this region as a way to tag specific isoforms for 
degradation. This mechanism may be used for controlling the ratio of 
Isoform 1 and 2, which affects telomere maintenance. With the Smg1 
homolog identified (Cristina Gonzalez-Estevez, unpublished) it is possible 
to conduct RNAi against the NMD pathway and observe changes in the 
isoform ratios. It is hypothesised that the enhancement of telomerase 
activity can be accomplished by shifting the splicing of Alt Region I-positive 
isoforms towards Isoform 1 (increasing the active form), and the splicing 
of Alt Region I-negative isoforms towards Isoform 4 (reducing competitive 
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inhibitors). In order to confirm this hypothesis, further experiments are 
needed to measure the transcription of individual isoforms. 
 
5.3.2 Post-transcriptional splicing control of telomere length 
dynamics 
Although the current data is not sufficient to show the abundance of 
individual isoforms, it can still provide a mechanical explanation to the 
telomere and telomerase dynamics observed in Chapter 3. The similar 
TRAP activities in intact samples of both strains correlate with the similar 
Alt Region I positive/negative ratios between these samples.  During 
regeneration, increase in the Alt Region I ratio coincides with the enhanced 
in vitro TRAP activities, this increase is conserved between the strains by 
lowering the transcription of Alt Region I-negative isoforms, and may serve 
to prevent rapid telomere attrition. In asexuals the decrease in the Alt 
Region I-negative isoforms is accompanied by the up-regulation of Alt 
Region I-positive isoforms which does not occur in the sexuals, resulting in 
a greater difference in the positive/negative ratio between the strains. The 
fainter TRAP band in the sexual regenerating samples may be due to the 
lower fold of increase in the positive/negative ratio, together with the lower 
total Smed_Tert transcription level compared to the asexual samples. The 
telomere length reset in the asexual strain during regeneration coincides 
nicely with the transcriptional and post-transcriptional Smed_Tert up-
regulation. Whereas the lack of Alt Region I-positive up-regulation in the 
sexuals may result in insufficient telomere maintenance and general 
telomere erosion after regeneration, despite the reduction in Alt Region I-
negative isoforms. 
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The significant decrease in the Alt Region II-positive isoforms in 
regenerating mature sexuals further supports the observation from the 
Smed_Tert in-situ hybridisation, which suggests that gamete-producing 
cells hold the majority of telomerase activity in sexual worms. This 
decrease was not observed in the juvenile sexuals, which may be due to 
the smaller proportion of proliferating germ cells in the body comparing to 
the mature worms, and a higher proportion of telomerase activity in soma 
during growth. The Smed_Tert expression in regenerating mature sexuals 
is generally lower than that in regenerating juveniles, suggesting a down 
regulation of Smed_Tert in soma after reaching maturity. 
 
5.3.3 Allelic variations of asexual Smed_Tert 
Three Smed_Tert haplotypes have been identified in the 15 RT-PCR clones 
derived from one individual asexual worm. Haplotype S is the sexual-like 
version of the transcript, with identical amino acid composition to the 
sexual Smed_Tert. Haplotype M1 contains SNPs, among which some 
results in polymorphisms at the amino acid level. Haplotype M2 appears to 
be a mixture between S and M1, most possibly as a result of a single 
crossover event between G837 and A/T1312. It can be expected that 
another haplotype, M3, should also be produced by this crossover, 
however this haplotype was not identified with the limited number of 
sequenced clones. 
 
 
Figure 5.3.1 ± Possible crossover event suggested by the three 
haplotypes currently identified. 
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Mutations in Smed_Tert have not been identified in the sexual clones. This 
suggests that Haplotype M1 arose from spontaneous random mutations 
after the branching of the asexual lineage from the common ancestor of 
the two strains. Alternatively, both Haplotype S and M1 may be possessed 
by the ancestor, and preserved by the asexual strain while the sexual 
strain abandoned M1. The asexual strain is in theory less capable of 
removing mutations in the genome due to the lack of meiotic 
UHFRPELQDWLRQ 7KLV LGHD DGYDQFHG IURP WKH RULJLQDO 0XOOHU¶V UDWFKHW
(Muller, 1964), predicts that allelic variations of a gene may be tolerated if 
the mutation does not affect the fitness of the stem cell within a 
population. The M haplotypes consist of all splicing variants, suggesting 
they are stably transcribed. Although the total number of sequenced clones 
(n = 15) is not enough to make a definite conclusion, no mutations, 
including silent mutations, were found in sexual-like Smed_Tert clones, 
supporting little recombination between the mutants and the wild type 
allele. Of the five identified mutation sites, two of those are silent 
mutations (T663C and T1740G for S215 and S574, respectively), two 
result in possible interchangeable residue variations (CA207-208GG and 
C865G for I63V and L282V, respectively), and one may have consequences 
in protein properties (A1340T for K440I). The K440I site locates at the 
beginning of the Motif D (see aa.885 in Appendix A) of the RT domain, in 
proximity to a previously studied human mutation site (K902N, end of 
Motif D) which results in loss of telomerase function and haploid 
insufficiency in dyskeratosis congenita patients (Armanios et al., 2005). It 
is not certain whether Haplotype M1 exist in all stem cells, or a sub-
population of these cells. Effects of these mutations can be studied in the 
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future by in vitro reconstruction when the telomerase RNA subunit is 
identified. 
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CHAPTER 6: UNFINISHED PROJECTS 
 
6.1 Introductions 
6.1.1 Discovery and characterisation of Pot1 homolog in S. 
mediterranea 
The full-length transcript of Smed_Pot1 (Protection of telomeres ± 1) has 
been recently identified by TBlastN and RACE. This protein is featured by 
the presence of at least one oligonucleotide/oligosaccharide binding fold 
(OB fold) which confers its affinity to single-stranded telomeric sequence 
(Horvath et al., 1998). POT1 is conserved between fission yeast and 
humans in sequence, in its ability to bind telomerLF¶RYHUKDQJ (Baumann 
and Cech, 2001) and in its role in maintaining the terminal loop structure 
and shielding telomeres from ATR-mediated DNA repair machinery (Guo et 
al., 2007). Similar to its structural homolog in budding yeast, CDC13, POT1 
also GHWHUPLQHV WKH OHQJWK RI ¶ RYHUKDQJ E\ controlling the access of 
telomerase (Kelleher et al., 2005, Veldman et al., 2004) and C-strand 
resectioning nucleases to telomeres (Garvik et al., 1995, Hockemeyer et 
al., 2005). Inhibition or deletion phenotypes of POT1 differ between 
organisms.  Deletion in S. pombe leads to rapid telomere loss, telomeric 
fusion and cell death (Baumann and Cech, 2001), similar to the 
phenotypes observed in the plant Arabidopsis thaliana after expression of a 
dominant negative allele of Pot2 (one of the POT1 orthologs) (Shakirov et 
al., 2005). In contrast, RNAi knockdown in human cells causes reduced 
proliferation, telomere lengthening, decreased ¶RYHUKDQJUDQGRPLVHG¶
terminal nucleotides, and formation of ǄH2AX DNA damage foci at 
telomeres but with only a mild increase in telomere fusion (2-fold, 
compared to 10-100 fold increase in TRF2 knockdown cells) (Hockemeyer 
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et al., 2005). Conditional knockout of POT1 in chicken DT40 cells results in 
cell arrest in G2 phase and increased telomere length, but instead of 
reduced ¶ RYHUKDQJs, cells with no POT1 expression have increased 
telomeric single-strand to double-strand ratio (Churikov et al., 2006), 
possibly due to increased access of telomerase to the open telomere 
structure and unregulated C-strand degradation. Two of the four identified 
POT1 homologs in C. elegans, CeOB1 and CeOB2, were shown to bind to 
the G-strand and C-strand (unique to the nematodes) overhang, 
respectively (Raices et al., 2008). Loss of CeOB1 by gene deletion leads to 
¶ RYHUKDQJ HORQJDWLRQ OLNHO\ LQ D WHORPHUDVH GHSHQGHQW PDQQHU ZKLOH
GHOHWLRQ RI &H2% FDXVHV KHWHURJHQHRXV OHQJWKHQLQJ RI ¶ RYHUKDQJV
which resembles the maintenance by ALT pathway. Together, these results 
demonstrate the rapid evolving nature of the POT1 gene to suit various 
requirements in telomere protection and maintenance in each organism. 
 
Since only one homolog of POT1 was identified in S. mediterranea, it is 
hypothesised that the function of this protein is similar to its relatives in 
other multicellular organisms with a single copy of the gene, such as 
human and chicken. It should possess ¶ RYHUKDQJ VSHFLILFLW\ UHJXODWH
overhang length, prevent ATR-mediated telomere damage signals, and the 
consequential cell cycle arrest at G2. 
 
In this project, RNAi of Smed_Pot1 was performed, and the effects of the 
gene inhibition were characterised. Expression level of marker genes 
(Eisenhoffer et al., 2008) for adult somatic stem cells (Category 1 cells, 
represented by Smedwi-2 expression) and their differentiated progenies 
(Category 2 and 3, represented by NB.21.11e and Agat1, respectively) 
were measured with qRT-PCR. Metaphase chromosome spreads were 
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carried out with regenerating Smed_Pot1 and dsRed RNAi samples (Day 3 
post amputation) to observe the effects of the gene inhibition on genome 
stability and cell proliferation. Various planned experiments will be 
discussed in the final section of this chapter. 
 
6.2 Results 
6.2.1 Gene discovery, protein annotation, and inhibition 
phenotypes of Smed_Pot1 
As shown in Figure 6.2.1, a region between G4317-G2569 on the negative 
strand of Contig v31.002347 encodes a 1371bp transcript which is 
translated into the 334aa Smed_POT1 protein. The site of highest 
homology with other species is Exon 3, forming the N-terminal OB1 fold of 
the protein, which was confirmed with the NCBI conserved domain search 
(Marchler-Bauer et al., 2011) matching the OB1 fold of human POT1 (for 
sequence alignment see Figure B1 in Appendix). A second OB2 fold was 
predicted by the Phyre software (Kelley and Sternberg, 2009), showing 
structural similarity to the OB2 fold of human POT1 (see Figure B2 in 
Appendix). 
 
The RNAi phenotype of Smed_Pot1 consists of an acute effect on the 
anterior axis, followed by persistent regeneration defects and tissue 
regression which led to death of the treated samples. All RNAi treated 
worms decreased in body size throughout the injection regime more 
rapidly than the dsRed controls. A small proportion of the worms lost their 
head region (from the middle point between the photoreceptors and the 
pharynx) within 1-4 days from the first injection, and regenerated a small 
head with normal eyes after 7 days. Following amputation (see Figure 
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6.2.2c), all samples developed regeneration blastemas which were smaller 
than those in the controls. Tissue regression occurred at various rates 
between samples, generally the existing head tissues started to regress 
after Day 10, and the posterior blastemas after Day 12. All middle pieces 
regenerated smaller heads compared to the controls, and in some samples 
these heads started regressing after Day 14.  All tail pieces had incomplete 
head regeneration, some did not form visible eyes and others had eye 
regression after Day 14. Death began to be observed from Day 14 in the 
most severe case, followed by other pieces with milder phenotypes at 
various time points. 78.3% of the pieces died by Day 30 while the 
remaining reverted back to wild type after the effect of RNAi diminished. 
The phenotypes and their abundances are listed in Table 6.2.1. 
 
 
Time point Type Description Abundance 
During injection 
regime 
Rapid body size 
reductions 
From ~9mm to 
~5mm 
60/60 (100%) 
1-4 days from 
the first injection 
Head lysis From between the 
eyes and the phaynx 
4/60 (6.67%) 
Day 5 post 
amputation 
Small blastema  60/60 pieces 
(100%) 
After Day 10 pa. Existing head 
regression 
In head pieces 19/20 pieces (95%) 
After Day 12 pa. Posterior 
blastema 
regression 
In head and middle 
pieces 
40/40 pieces 
(100%) 
After Day 14 pa. Regression of 
regenerated 
small head 
In middle and tail 
pieces 
11/20 middle 
(55%), 19/20 tail 
(95%) 
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Varies widely, 
From Day 14 pa. 
Death Total death counted 
on Day 30 pa. 
18/20 head (90%), 
10/20 middle 
(50%), 19/20 tail 
(95%) 
After Day 30 pa. Rescue Reverted back to wild 
type. 
1/20 head (10%), 
10/20 middle 
(50%), 1/20 tail 
(5%) 
Table 6.2.1 ± Smed_Pot1 RNAi phenotypes and their penetrance. 
qRT-PCR on category marker expression (done in three replicates on 
batches of five worms each) displayed an average decrease of 84.3% in 
Smedwi-2, 99.8% in NB.21.11e, and 94.6% in Agat1 (s.d.= 1.33%, 
0.0534%, and 0.299%, respectively) in RNAi samples on Day 17 post 
amputation, as shown in Figure 6.2.2a.  The metaphase chromosome 
spread (see Figure 6.2.2b) in Smed_Pot1 RNAi samples showed a 
reduction in mitotic figure, accompanied by an increased ratio of prophase 
cells (8 in 20 counted cells). In contrast, metaphase chromosomes were 
more abundant in the dsRed controls, with 1 prophase cell in 50 cells 
totally counted.  
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Figure 6.2.1 ± Gene and protein annotation of Smed_POT1. (A-B) 
The 331aa protein is translated from a 1369bp transcript which is mapped 
to the genomic Contig v31.002347. The OB1 fold was mapped with the 
NCBI conserved domain search, while the OB2 fold was predicted with 
Phyre online software. (C) Multi-species alignment and phylogram of POT1 
proteins, showing their relative sizes and domain distributions (protein 
sequences obtained from NCBI RefSeq protein database). (D) The 
evolutionary tree of POT1 computed using the Minimum Evolution method 
with MEGA5 software. The branch lengths are drawn to scale, in the units 
of the number of amino acid substitutions per site. 
 133 
 
 
Figure 6.2.2 ± Current Smed_Pot1 phenotypic characterisations. 
(A) Expression levels of category cell markers in the Smed_Pot1 RNAi 
treated samples on Day 17 post-amputation, shown as ratios to the levels 
in the dsRed control samples (n = 3). (B) Metaphase chromosome spread 
of 72hr regenerating sexual samples. Worms treated with Smed_Pot1 RNAi 
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are featured by low mitotic figures and a high abundance of prophase 
chromosomes and telomere fusions (n = 150). (C) Regeneration defects 
and tissue regressions in Smed_Pot1 RNAi samples. Time points are shown 
as days post-amputation. Scale bar = 0.5mm. 
 
6.3 Discussion 
6.3.1 Smed_Pot1 RNAi may cause G2 arrests and gradual stem 
cell depletions 
As reviewed in the introduction, POT1 protein evolves rapidly between 
species. S. mediterranea has a single copy of the Pot1 gene, and the 
protein is small and compact compared to other organisms in the 
alignment. The Smed_POT1 is unique in a way that the two OB folds are 
located at either end of the protein, while these folds are commonly found 
in the N-terminal region in other organisms. The ability of regenerating 
worms to grow missing heads and eyes suggests that the Smed_Pot1 RNAi 
worms are still able to induce cell proliferation and differentiation, possibly 
due to residual Smed_POT1 protein binding at the telomere ends of 
proliferating cells which prevent the formation of DNA damage signals. The 
smaller size of the regenerated tissues correlates with the low mitotic 
figure observed in the metaphase chromosome spread on Day 3 post 
amputation, which indicates that some stem cells were starting to lose 
their proliferative capacity. The high abundance of prophase cells suggests 
a cell cycle arrest at late G2, when chromatin begins to condense. It is 
likely that as the experiment progressed, residual Smed_POT1 protein in 
cells began to deplete, resulting in more cellular arrest and apoptosis. This 
progressive reduction of proliferative stem cells led to inability to maintain 
existing tissues, causing regression which is more visible in body regions 
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with high turnover rates. The Category 2 cells have been previously shown 
as a population of transient and short-living stem cell progeny which 
differentiate into Category 3 cells approximately four days after division 
from the stem cells (Eisenhoffer et al., 2008). Prompt removal of stem 
cells by irradiation causes down regulation of Category 2 markers in two 
days, and Category 3 markers in three to four days. Since both Category 2 
and 3 cells are concentrated in an area anterior to the photoreceptors, 
regression of this area in Smed_Pot1 RNAi samples was most prominent. 
The category marker expressions on Day 17 post amputation also indicate 
a failure in the homeostasis of category cells. 15.7% of Smedwi-2 stem cell 
marker expression remained in the Smed_Pot1 RNAi samples, these 
remaining cells were either quiescent or senescent, and could not give rise 
to the short-living Category 2 cell population, as indicated by the 0.23% 
remaining NB21.11e expression. The lack of Category 2 cells resulted in 
depletion of the relatively long-living Category 3 cells, with 5.4% 
remaining marker expression. 
 
Several experiments are currently in plan to fully characterise the 
Smed_Pot1 RNAi phenotype. Samples at various time points post 
amputation should be analysed with FACS to look for the accumulation of 
4n DNA cells, which provides supporting evidence for G2 arrest. The arrest 
and apoptosis are most likely to be mediated by ATR, and therefore the 
phenotypes should be alleviated by RNAi against ATR. The samples should 
also be stained with the anti-phosphorylated histone H3 serine 10 antibody 
which can provide evidence for reduced proliferation. Levels of activated 
caspase 3 should be measured in the samples as evidence for increased 
cell death. Whole mount in-situ hybridisation should be done with category 
markers to confirm the results of the qRT-PCR. 
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Since the nucleoprotein complex structure at the telomere has not been 
previously studied in planarians, it is important to understand whether 
Smed_Pot1 inhibition causes DNA damage signals specifically at the 
telomeres. Previous western experiments have shown that the anti-Ǆ+$;
serine 139 antibody (Cell Signalling) have failed to produce signals with 
irradiated S. mediterranea (data not shown). Antibodies against other 
SKRVSKRU\ODWHG VHULQHV DUH \HW WR EH WHVWHG 7KH OHQJWK RI ¶ RYHUKDQJ
should also be measured at different time points using non-denaturing TRF 
analysis. As contradictory results in the overhang dynamics of Pot1 
inhibited cells have been found in different organisms, it is intriguing to see 
how POT1 functions in vivo in an invertebrate model with canonical 
(TTAGGG)n telomere repeats and with cells in their natural niches. 
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CHAPTER 7: CONCLUSIONS 
 
7.1 Telomerase activity in adult stem cells is adapted to an 
immortal life history in obligate asexual S. mediterranea 
As discussed in Chapter 3, the asexual strain of S. mediterranea 
replenishes its somatic telomeres through periodic fission and 
regeneration. The RNAi experiment in Chapter 4 has confirmed that this 
reset is telomerase dependent, and the target length for the reset may be 
determined by a stem cell population with the longest telomeres. Results 
from Chapter 5 indicate that the reset involves transcriptional up-
regulation of the Smed_Tert gene, as well as post-transcriptional splicing 
regulation, which result in enrichment of the full-length Smed_Tert isoform 
and down regulation of isoforms lacking intact TRBD regions. In contrast, 
this regeneration-associated somatic reset is absent in the sexual strain, 
which maintains its telomeres via passage through the germline, a 
common mechanism in multicellular organisms (Figure 7.1.1A and C).  
 
Smed_Tert isoforms containing truncated TRBD are predominant in intact 
worms and decrease during regeneration. This decrease correlates with the 
enhancement of TRAP activity in these samples, suggesting a possible 
inhibitory property of these isoforms. Since mutations in TRBD in human 
and yeast impair interaction with the telomerase RNA subunit and 
holoenzyme dimerisation, these isoforms are not likely to possess 
telomere-maintaining function, but can possibly still associate with 
telomeres via protein-protein interactions between the POT1/TPP1 complex 
and/or CST complex with their N and C-terminal regions, and compete with 
the functional full-length isoform (Figure 7.1.1B). 
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Unlike a previous observation in colonial ascidian Diplosoma listerianum 
which requires occasional sexual reproduction to achieve rejuvenation 
(Sköld et al., 2011), asexual S. mediterranea has evolved a mechanism 
that makes its somatic stem cells effective units of inheritance. The reset 
mechanism prevents telomere depletion caused by the end replication 
problem over an evolutionary timescale, and demonstrates the adaptation 
to the agametic asexual life mode, including immortalisation of somatic 
stem cells in their native niche. Further study is required to understand 
how the regeneration-induced Smed_Tert transcription and splicing is 
regulated, and how the regulation differs between the strains; this will 
involve comparisons between the promoter region of the gene, as well as 
exonic/intronic splicing regulatory motifs throughout the gene. This plan 
requires a sequenced genome of the asexual strain, which is currently not 
available. An alternative approach is to isolate the entire genomic region 
surrounding the Smed_Tert gene (approximately 20kb) by Tranformation 
associated recombination (TAR) cloning, followed by sequencing of the 
clones. 
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Figure 7.1.1 ± Splicing control of telomerase activity and telomere 
reset in pASCs of asexual and sexual strains. (A) Sexual germline is 
derived from somatic pASCs. Unlike the telomere reset in asexual pASCs 
during regeneration, telomeres in the sexual strain are reset in the 
germline, during gametogenesis or embryogenesis. (B) Alternate splicings 
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of Smed-Tert alternate region I produce isoforms with truncated TRBD, 
which is thought to cause failure in interactions with the telomerase RNA 
subunit (TR) and a consequent lack of telomerase activity. Reduction in the 
TRBD negative isoforms during regeneration correlates with the increase in 
telomerase activity, indicating that these isoforms may act as competitive 
or dominant negative inhibitors of telomerase. (C) Comparison of the 
isoform expression levels between homeostatic and regenerating pASCs in 
both strains. Significant up-regulation of the intact/truncated TRBD ratio 
during regeneration coincides with enhanced TRAP activity and telomere 
length reset in the asexual strain. While a slight increase in the ratio in the 
sexual regenerating pASCs is not sufficient to prevent telomere erosions 
during rapid cell divisions. 
 
7.2 S. mediterranea as an in vivo model for telomere biology in 
adult multicellular organisms 
Although the telomeric regions in S. mediterranea have yet to be cloned 
and sequenced, the presence of (TTAGGG)n arrays in the genome, 
together with the sensitivity of the (TTAGGG)n signals to Bal-31 in the TRF 
analysis and its decrease in length in Smed_Tert RNAi treated samples, 
have indicated that S. mediterranea utilises the same telomeric repeat unit 
as previously found in Polycelis tenuis. This repeat unit is commonly 
possessed by organisms across the eukaryotic kingdom, such as the 
filamentous fungi Neurospora crassa (Schechtman, 1990), acellular slime 
moulds Didymium iridis and Physarum polycephalumthought (Forney et al., 
1987), kinetoplastid protozoan Trypanosoma brucei (Blackburn and 
Challoner, 1984, Van der Ploeg et al., 1984), sponge species (Porifera) 
(Sakai et al., 2007), annelid worms (Vitturi et al., 2000, Jha et al., 1995), 
molluscs (Wang and Guo, 2001, Sakai et al., 2005, Gallardo-Escarate et 
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al., 2005), velvet worms (Onychophora) (Vitkova et al., 2005), and among 
vertebrate species (Meyne et al., 1989), and is therefore likely to be the 
ancestral telomeric sequence of the eukaryotes. The presence of 
telomerase and its vertebrate-like 6bp processivity indicates a canonical 
telomere maintenance mechanism in planarians. Although it is not certain 
if planarians SRVVHVV ¶ WHORPHULF RYHUKDQJV VLPLODU WR C. elegans, the 
single copy of Pot1 in S. mediterranea suggests a single type of overhang, 
which is most likely to be the FRPPRQ¶ VWUHWFKHV In addition to TERT 
and POT1, bioinformatic analysis has also preliminarily suggested the 
presence of various telomere associated protein homologs including TRF2, 
RAP1, Tankyrase, BLM helicase, DNA-PK and the checkpoint-activating ATM 
and ATR kinases (details listed in Table 7.1). These genes have not been 
studied in planarians. Other shelterin complex proteins may be present but 
cannot be identified with the current transcriptome assembly, it is 
expected that the universally conserved OB fold containing CST complex 
(Cdc13-Stn1-Ten1 in budding yeast (Gao et al., 2007), CTC1-STN1-TEN1 
in mammalians (Miyake et al., 2009) and plants (Surovtseva et al., 2009)), 
which binds to the single stranded telomeric overhangs, should also be 
present in S. mediterranea. 
 
 
Protein EST name Top hit organism E 
Value 
TRF2 lcl_AAA.454ESTABI.7659 Taeniopygia guttata 0.083 
RAP1 lcl_AAA.454ESTABI.16947 Strongylocentrotus 
purpuratus 
4e-13 
ATM lcl_AAA.454ESTABI.12461 Ciona intestinalis 3e-56 
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ATR ec1.14936.001 Taeniopygia guttata 4e-44 
 v31.013442_4105..19586 Callithrix jacchus 2e-08 
Tankyrase lcl_AAA.454ESTABI.21226 Saccoglossus 
kowalevskii 
5e-138 
DNA-PK lcl_AAA.454ESTABI.10238 Polysphondylium 
pallidum PN500 
8e-28 
 lcl_AAA.454ESTABI.12021 Canis lupus familiaris 7e-17 
BLM (Bloom 
syndrome) 
lcl_AAA.454ESTABI.21054 Acyrthosiphon pisum 3e-165 
 
Table 7.1 ± Preliminarily identified telomere-associated protein 
homologs. 
 
Models commonly used in telomere studies consist of ex vivo cell cultures 
of higher vertebrates in the absence of native cellular environments, in 
vivo studies in higher vertebrates (mouse and chicken) which are difficult 
to characterise in adults, or simple in vivo models (yeasts, ciliates, and 
nematodes) which have diverged telomeric repeats or structures. S. 
mediterranea possesses the (TTAGGG)n telomere tandem repeat 
maintained by the telomerase holoenzyme. Studies in this organism can 
take advantages of these canonical properties, as well as the native in vivo 
adult stem cell niches in which genes are easily manipulable by RNAi, and 
whole body phenotypes can be easily analysed and monitored by the 
improving molecular techniques which are being made available to 
planarians. Distribution and number of proliferating cells in dysfunctional 
telomere backgrounds can be observed by the phospho-histone H3S10 
immunohistochemistry, cells with proliferative capacities can be monitored 
by in situ hybridisations and qPCR using various markers such as PCNA and 
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Category 1 genes, and their developmental progenies can be assessed with 
Category 2, 3 and other tissue specific markers. The improving 
understanding of cell lineages and cell type specific genes, together with 
the ability of adult worms to reset developmental pathways during 
regeneration, make this planarian species a robust tool for studying the 
developmental functions of telomere associated genes, such as the role of 
TERT in Wnt regulation. Although the Smed_Tert inhibition by RNAi was 
not sufficient to induce developmental defects, it is hoped that a transgenic 
conditional knockout approach can be adopted in the future. 
 
In addition to the advantages provided by the simplicity of whole body 
characterisations, this organism also possesses complex reproductive cells 
with high telomere maintenance activities, which can be used for 
understanding how telomerase can be regulated in the germline. Current 
results from the expression levels of Smed_Tert isoforms suggest an 
important role of splicing control in the regulation of telomere maintenance 
in both sexual and asexual strains. Whether this control involves dominant 
negative isoform(s) and/or the nonsense-mediated decay pathway requires 
further experiments. 
 
In this PhD project several common techniques in telomere studies have 
been applied and optimised in this organism. Telomere length was 
measured using TRF and qPCR, telomerase activities were assayed using 
TRAP, and cellular consequences of Smed_Pot1 RNAi was observed by 
metaphase chromosome spreads (previously optimised by (Lamatsch et 
al., 1998)). Various techniques can be optimised for future telomere 
studies. Proportions of proliferating and G2 arrested stem cells in the 
whole body can be measured with FACS by their DNA contents, and 
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analysed in greater depth after sorting. FACS with double-labelled 
dissociated cells can also be useful for studying the cell-type specificity of 
telomere lengths. In vitro telomerase reconstruction is needed for studying 
the functions of splicing and mutational variants of Smed_Tert, it is 
therefore necessary to identify the RNA subunit of telomerase (TERC) in 
this species. The universally conserved secondary structure of the RNA and 
the presence of telomeric repeats should allow bioinformatic predictions of 
possible sequences from the genomic and transcriptomic database. 
 
Furthermore, development of transgenic epitope tagging, gene deletion 
and over-expression are necessary for complete functional and quantitative 
studies of proteins in planarians. An electroporation-based method for 
transposase-mediated genome integration and stable expression of an 
extrinsic gene has been previously applied to a neighbouring species 
Girardia tigrina with a Pax6-specific promoter (Gonzalez-Estevez et al., 
2003). However application of various approaches, including 
electroporation and viral transfection, has yet to produce expressed 
transgenes in S. mediterranea. Identification of strong and ubiquitous 
promoters for this species may be a major current obstacle (Cristina 
Gonzalez-Estevez and Sunir Malla, personal communication). 
 
As reviewed in Chapter 1, oxidative stress can cause sudden and massive 
loss of telomeric sequences. However whether the natural accumulation of 
ROS is sufficient to erode telomeres in vivo requires experimental 
evidence. The significance of ROS in the maintenance of the natural stem 
cell pool and whole body ageing can be assessed with comparative studies 
between the immortal asexual strain and ageing sexual strain. Biochemical 
assays for activities of antioxidants such as catalase and superoxide 
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dismutase have been previously applied to planarians (Li, 2008), and can 
be used to test whether the asexual strain has a higher level of defence 
against oxidative damages. Genes encoding for these antioxidants can be 
inhibited and their effects on telomere length can be observed. A more 
sensitive method for telomere length measurement may be required to see 
these effects. Recent development of the universal Single telomere length 
analysis (STELA) technique may provide sufficient resolution for this 
purpose, however the maximum detection length of this method seems to 
be limited by the processivity of the DNA polymerase in the PCR reaction, 
which was found to be approximately 8kb (Bendix et al., 2010). Smed_Tert 
inhibition has created a line of asexual S. mediterranea with a stable mean 
telomere of less than 10kb (shown in the Week 57 sample of Figure 
4.2.4b), which makes the application of this technique a possibility. 
 
7.3 S. mediterranea as a model for ageing in multicellular 
organisms 
One of the major steps towards adaptation to the asexual life history is the 
ability to prevent senescence of the soma. The most prominent difference 
in telomere dynamics between the sexual and asexual strains occurs 
during regeneration. Decrease in the transcription of Alt Region I-negative 
isoforms is observed in both strains, the consequential rise in the 
positive/negative ratio of the isoforms containing this region may provide a 
basal protection against massive telomere erosion during rapid cell 
divisions. The up-regulation of total Smed_Tert transcription in somatic 
stem cells during regeneration is unique to the asexual strain, and 
therefore should play an essential role in immortalising the soma. On the 
other hand, the age-related telomere erosion and lack of length reset in 
the sexual strain indicates its mortal nature, which is also suggested by the 
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limited life spans of closely related sexual planarian species previously 
studied (Child, 1914, Haranghy and Balázs, 1964). Genes of which 
regulation contributes to the fundamental difference in somatic mortality 
between the sexual and asexual strains may affect the life span of other 
organisms as well. Previous proteomic work has predicted the association 
of 2,163 human proteins to human homologs of known longevity-related 
proteins in yeast and invertebrates (Bell et al., 2009). Some of these 
associated proteins also showed effects on longevity in C. elegans, showing 
a conservation of the protein network which controls ageing in human and 
invertebrates. Recent improvement in transcriptomic sequencing using a 
combination of two next generation sequencing platforms has allowed a 
complete bird¶V-eye view of gene regulation between samples (Blythe et 
al., 2010). It is now possible to discover ageing related genes with an 
approach alternative to prediction based on protein associations, by direct 
comparison between the transcriptome of the two strains during 
regeneration. This PhD project has focused on telomere related genes due 
to the essentiality of telomere maintenance for immortal soma, however 
the regulators of cellular maintenance are yet to be fully discovered. 
Elements regulating the ageing process may also involve germline property 
specifications, energy metabolism, oxidative damage removal, and DNA 
damage repair. It is hoped that the result of this transcriptomic approach, 
using two strains of the same species with opposite somatic mortalities, 
can be combined with the previous proteomic prediction to produce 
significant candidates for experimental characterisations. 
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APPENDIX A 
Multi-species alignment of TERT using ClustalW2 
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Figure A1 ± ClustalW protein sequence alignment of TERT in 
several distantly related species. Conserved sequence motifs in S. 
mediterranea were identified by alignment with TERT proteins in Homo 
sapiens (accession number O14746.1), Fugu rubripes (AAX59693.1), 
Tetrahymena thermophila (O77448.1), and Est2p in Saccharomyces 
cerevisiae (Q06163.1). Alignment was performed on the EMBL-EBI 
ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) with default 
parameters. 
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APPENDIX B 
 
POT1 OB1 and OB2 domain alignment 
 
 
 
 
 
Figure B1 ± Mapping of OB1 fold by homology. The N-terminal region 
of POT1 in S. mediterranea contains sequence highly similar to the OB1 
fold in human POT1. 
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Figure B2 ± Prediction of OB2 fold by Phyre, showing consensus 
structures shared between the human POT1 OB2 and POT1 in S. 
mediterranea (e = 4.4 x 10-7). 
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